 
 KEYS TO STAYING SHARP  
 
 
 
Interventions to Attenuate Cognitive Decline  
     
Supported by:  
 
[CONTACT_236276]  
 
R01 AG056428 
 
Principal Investigator:  [INVESTIGATOR_236181] 2 
     08/08/2018 
Page 2 of 58  
 Table of Contents  
1 SYNOPSIS  ..................................................................................................................................................... 5 
1.1 Study Title  ............................................................................................................................................................................... 5 
1.2 Objectives  ................................................................................................................................................................................ 5 
1.3 Design  ...................................................................................................................................................................................... 5 
1.4 Outcomes  ................................................................................................................................................................................. 5 
1.5 Interventions and Duration  ..................................................................................................................................................... 5 
2 STUDY OBJECTI VES  ................................ ................................ ................................ ............................  7 
2.1 Primary Objective  ................................................................................................................................................................... 7 
2.2 Secondary Objectives  .............................................................................................................................................................. 7 
3 BACKG ROUND  ................................ ................................ ................................ ................................ ...... 8 
4 STUDY DESIGN  ................................ ................................ ................................ ................................ .... 11 
5 SELECTION AND ENROLLMENT OF PARTICIPANTS  ................................ ................................  11 
5.1 Inclusion Criteria  .................................................................................................................................................................. 11 
5.2 Exclusion Criteria  .................................................................................................................................................................. 11 
5.3 Enrollment Procedures  .......................................................................................................................................................... 13 
5.4 Describe consent procedures.  ................................................................................................................................................ 14 
5.5 Describe the procedure for obtaining intervention group assignment  ................................................................................. 15 
5.6 STUDY INTERVENTIONS  .................................................................................................................................................. 16 
5.7 Interventions, Administration, and Duration ....................................................................................................................... 16 
5.7.1  Prohibited Interventions  ........................................................................................................................................................ 16 
5.8 Adherence Assessment  .......................................................................................................................................................... 17 
6 CLINICAL AND LABORATORY EVALUATIONS  ................................ ................................ ..........  18 
6.1 Timing of Evaluations  ........................................................................................................................................................... 21 
6.1.1  Pre-Randomization Evaluations  ............................................................................................................................................ 22 
 Keys to Staying Sharp 
  Version 2 
     08/08/[ADDRESS_285975] Timeline  ....................................................................................................................................................... 23 
6.3 Intervention Discontinuation Evaluations Rete ntion  ............................................................................................................ 24 
6.3.1  Retention  ............................................................................................................................................................................... 24 
6.3.2  Documentation of MCI or dementia  ..................................................................................................................................... 25 
6.3.3  Concomitant Treatments  ....................................................................................................................................................... 25 
6.3.4  Study Intervention Modifications  ......................................................................................................................................... 25 
6.3.5  Measures  ............................................................................................................................................................................... 25 
6.3.6  Questionnaires  ...................................................................................................................................................................... 30 
7 MANAGEMENT OF ADVERSE EVENTS  ................................ ................................ .........................  31 
8 CRITERIA FOR PARTICIPANT DISCONTINUATION  ................................ ................................ .. 31 
9 STATISTICAL CONSIDERATIONS  ................................ ................................ ................................ .. 31 
9.1 General Design Issues  ............................................................................................................................................................ 31 
9.2 Primary Objectives  ................................................................................................................................................................ 31 
9.2.1  Primary outcomes  .................................................................................................................................................................  32 
Secondary Objectives  ..................................................................................................................................................................... 32 
9.3 Sample Size  ............................................................................................................................................................................ 32 
9.4 Data Monitoring .................................................................................................................................................................... 33 
9.5 Interim Data Analyse s ........................................................................................................................................................... 33 
9.6 Final Data Analyses  ............................................................................................................................................................... 34 
9.7 Sensitivity Analyses  ............................................................................................................................................................... 36 
9.8 Exploratory Subgroup Analyses  ........................................................................................................................................... 36 
10 DATA COLLECTION, SITE MONITORING, AND ADVERSE EXPERIENCE REPORTING  .... 38 
10.1 Records to Be Kep t ................................................................................................................................................................ 38 
10.2 Data Management  .................................................................................................................................................................  38 
10.2.1  Clinical site responsibilities in data collection and management.  .................................................................................... 38 
11 QUALITY ASSURANCE  ................................ ................................ ................................ ......................  39 
11.1 Adverse Experience Reporting  .............................................................................................................................................. 40 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 4 of 58  
 11.2 Follow -up for Adverse  Events  ............................................................................................................................................... 41 
11.3 Safety Monitoring  .................................................................................................................................................................. 41 
11.4 Confidentiality  ....................................................................................................................................................................... 41 
11.5 Study Modification/Discontinuation ..................................................................................................................................... [ADDRESS_285976] sizes for pi[INVESTIGATOR_236182], among those adherent, and by [CONTACT_236277] . 57 
 
15. CONSORT CHART  59 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 5 of 58  
 1 SYNOPSIS  
1.1  Study Title  
Interventions to Attentuate Cognitive Decline :  Keys to Staying Sharp.  
1.2  Objec tives 
 
The prim ary objectives are:  
 
• To examine the efficacy of pi[INVESTIGATOR_236183] (CAP), cogni tion, and 
everyday function among older adults  with and without mild cognitive impairment (MCI) .  
 The secondary obj ectives are:
 
• To examine th e moderating effects of MCI on pi[INVESTIGATOR_236184].   
• To explore mediators of intervention effects.  
 
1.[ADDRESS_285977] ion to improve CAP, cognition, and everyday function in older adults with and without MCI 
across two time points (baseline and immediate post- test). This is a phase II trial to test the efficacy of promis-
ing behavioral intervention (i.e., pi[INVESTIGATOR_236185]) i n a research setting. The primary outcome of interest is cogni-
tion
1. 
 
1.4  Outcomes  
 
We will quantify the effects of pi[INVESTIGATOR_236186], cognition, and everyday functional performance.  
 CAP  measures will include :  Time Compressed Speech  65% , Words -in-Noise, Dichotic Digits Test, Dicho tic 
Sentence Identification, and Adaptive Test s of Temp oral Resolution. 
 Cognition measures will include :  Verbal Fluency Test (phone mic fluency, cat egory fluency, and category 
switching ), Trail Making  Test, and Digit Coding. 
 Everyday Function measures will include :  Timed Instrumental Activities of Daily Living and Test of Everyday 
Attention . 
 
1.[ADDRESS_285978] of basic pi[INVESTIGATOR_236187], dexterity exercises, pi[INVESTIGATOR_236188], and 
music theory.  At each bi -weekly training session, participants will be  trained in groups and will be  expected to 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 6 of 58  
 perform all te chnique (sc ales/finger dex terity exercises), pi[INVESTIGATOR_236189] (Alfred Basic All -in-One Method), 
and complete music theory assignments.  Each class session will be stru ctured with a short review  followed by 
[CONTACT_236278] (e.g., s cales; chor d progressions)  and concept formation (e.g., inte r-
vals).  At least one five -minute break will occur in each session.   
 
Music Listening Instruction Condition .  Participants randomized to the music listening instruction  condition 
will engage in m usic listen ing and appreci ation .  The participants read about, listen to, view diagrams of, and 
answer questions about the music.  Each lesson  will cover chapters from  Music Listening Today  over 90 
minutes.   Each lesson will be structured as follows:  Overv iew of chap ter material an d group listening activity, 
participants  read over c hapter on their own, active  listening activity, five question quiz , overview of next chap-
ter material and group  listening activity , participants read over chapter on their own, a ctive liste ning activity, 
and five question quiz .  At least one five -minute break will occur in each session.  This structure is equivalent to 
the switching between ensemble/individual approach to teaching in the pi[INVESTIGATOR_236190].   The two trainin g conditions  will be equiv alent in terms of frequency  and duration of each session (90 min/day, 
two days/wk, 10 weeks)  and social contact (led by [CONTACT_236279] 10 persons) .  Both 
conditions will be described as “music training”.   
 Sample S ize and Populat ion 
 Our goal is to have up to 360 participants complete the study.  Individuals with normal cognition and those with 
a clinical diagnosis of MCI  will be recruited for this study.  Inclusion and exclusion criteria are detailed bel ow. 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 7 of 58  
 2 STUDY OBJECTIVES  
2.1  Primary Objective  
The primary objective is:  
 
• To examine the efficacy of pi[INVESTIGATOR_236191], cognition, and everyday function among 
older adults  across  baseline to immediate post- test.  We will assess the effects of pi[CONTACT_1629] o training (in ter-
vention) as compared to music lis tening instruction  (active control)  on CAP, cognition, and everyday 
function.  The primary outcome of interest is cognition.  
 
Hypotheses:  The pi[INVESTIGATOR_236192] C AP, cognition, and everyday function immediately post- intervention.  
 
Rationale : The efficacy of a novel intervention will be established relative to an active control group.  
There is compelling evidence that CAP deficits contrib ute to cognitive difficulties  2-5 and are a risk fac-
tor for dementia  3, 6, 7.  We propose that enhancing CAP may be particularly important to improve cogni-
tive function.  Formal music training is longitudinally associated with  enhanced C AP and successf ul 
cognitive aging.  Pi[INVESTIGATOR_236193] a feasible, potentially effic acious intervention to improve older adults’ 
CAP and cognition.  
 
2.2  Secondary Objectives  
The secondary objectives are:  
 
• To examine the moderating effects of MCI  on pi[INVESTIGATOR_236194].  Moderating effects of MCI status 
will determine if pi[INVESTIGATOR_236195]/or without MCI.  
  Rationale:  It is possible that pi[INVESTIGATOR_236196], but not in those w ith 
MCI.  It is also possi ble that cognitive and/or functional abilities may be differentially enhanced among 
those with and without MCI.  Delineating the effects of pi[INVESTIGATOR_236197], and for what specific outcomes.  We 
do not have a directional hypothesis for this objective.  
 
• To ex plore mediators of intervention effects.  
 Hypothesis : Grounded in theory
[ADDRESS_285979] that enhanced CAP will mediate cognitive gains.  We further hypothesize that cognitive gains will mediate fun ctional im-
prove ments.   
 Rationale : Crucially, we must discern the underlying mechanisms of effective interventions in order to 
maximize training gains.  
 
 Keys to Staying Sharp 
  Version 2 
     08/08/[ADDRESS_285980] feared signs of aging12-14.  In addition to the obvious 
health and quality- of-life ramifications for older adults, there are high economic costs (e.g., subsidizing nursing 
home care; lost productivity of family caregivers), when older adults can no longer live independently15.  Thus, 
preve ntion of cognitive and subsequent functional decline among older adults is of critical importance to public 
health.  Dementia is the most expensive medical cond ition and incre ases in prevalence with age16, 17.  Given that 
older adults are the fastest growin g segment of the population18, the prevalence of dementia (and its precur sor, 
mild cognitive impairment- MCI) has been increasing rapi[INVESTIGATOR_375]19.  Therefore, finding effective strategies for inte r-
vention to prevent or delay deme ntia is imperative t o improve publi c health.  The contribution of the proposed 
research is expected to be the identification of a novel and effective cognitive intervention to counter age -
related cogn itive and functional decline, which could potentially delay dementia onset.  We will elucid ate the 
underlying mechanisms of effective interventions to facilitate maximizing cognitive gains and improving eve-
ryday function.  The contribution of this research will be significant in that if an intervention could de lay the 
onset of Alz heimer’s diseas e by [CONTACT_236280], there would be about 9.2 million fewer cases of the di sease in 
205020, substantially lessening the burden.  Results will inform subsequent research and clinical practice by f a-
cilitatin g the design and implementation of effective interventions to atten uate cognitive decline and thereby 
[CONTACT_236281].  
Mild Cognitive Impairment (MCI).  Cognitive status has been conceptualized on a continuum from 
normal cognition to clini cally ascer tained dementia such as Alzheimer’s disease.  MCI represents a transitional 
phase between normal aging and dementia21, 22.  MCI patients have higher risk of developi[INVESTIGATOR_6124]12, 23 with 
conversion to dementia of ~12% per year23 (although not all individuals progress across this continuum).  
Among individuals with and without MCI, cognitive interventi ons may enh ance cognition and maintain ever y-
day functioning, thereby [CONTACT_236282]24.  A paucity of  research and methodologic al inadequacies 
have limited the implementation of effective cognitive interventions in MCI25, 26.  One avenue to enhan ce cogn i-
tion is the facilitation of central auditory processing ( CAP ) at initial perceptual stages5, which may potentially 
be achieved by [CONTACT_21173][INVESTIGATOR_236185].  Our scien tific premise is that pi[CONTACT_1629] o training will enhance CAP, resulting in i m-
proved cognition and subsequently everyday function, thereby [CONTACT_236283].  The primary outcome of interest is cognition.  
Central Auditory Processing (CAP).  One early  indicator of cognitive im pairment is impaired auditory 
processing. Auditory processing and decoding of sound occurs at multiple levels of the central auditory nervous system.  Central auditory processing dysfunction is characterized by [CONTACT_236284] s upra-thresh old sound, 
such as poor monaural speech -in-noise perception, binaural speech processing, sound localization and lateral i-
zation, and auditory processing speed 
27.  When CAP  is impaired, information received  by [CONTACT_236285], causing information processing difficulties. Auditory processing thus requires greater cognitive resources, negatively affecting memory and executive function 
8.  Decades of research have 
established that CAP is fun damentally linked with memory and executive functioning4, 5, 28, 29, which are the 
primary deficits in MCI and de mentia30, 31.  In su pport of this premise, CAP longitudinally predicts MCI and 
dementia such as Alzheimer’s disease32-34.  Prior research ( e.g., 35, 36) and our pi[INVESTIGATOR_236198], independent predi ctors of cognitive function (e.g., memory, execut ive function), and that 
adults with MCI show significant CAP deficits37, 38.  Deficits in CAP are multifaceted and  represented by [CONTACT_236286]-
culties with, for example, auditory speed of processing, monaural speech -in-noise recognition, binaural speech 
processing, sound localiz ation and lateralization, and auditory pattern recognition5, 39.  Note that auditory speed 
of processing, a leading indicator of cognitive aging, is one of the key el ements of CAP40, as adequate sensory 
functioni ng is funda mental for norm al speed of processing41.  When CAP is impaired, information received by 
[CONTACT_236287], causing information processing difficulties.  Auditory pr o-
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 9 of 58  
 cessing thus requires greater cognitive resources, negatively affecting memory and executive function8.  There-
fore, impaired CAP impedes cognitive performance41-45.  In addition to behavioral data, neuroanatomical evi-
dence documents that deficits in CAP46 are related to anterior temp oral lobe atrophy and reduced glucose me-
tabolism46-50, brain changes evident in MCI and Alzheimer’s disease51.  Neuroimaging further indicates a link 
between sensory function and cortical integrity, and that decreased volume in the auditory cortex cas cades to 
affect higher -order cognitive processing52-54.  In older adults, difficulties with CAP are associated with modified 
patterns of neural activation as well as with reduced gray matter volume in the auditory cortex.  Wong et al. and 
others55, 56 demonstrated that older adults show less activation in the auditory cortex and increased activation in 
the prefrontal cortex to perform cognitive tasks due to declines in CAP.  
Although CAP is a strong longitudinal predictor of cognitive decline, MCI, and dementia3, 34, 35, 57, prior 
research has not examined the effects of interventions targeting CAP on functional abi lities of older  adults with 
and without MCI.  Re -establishing and/or maintaining adequate CAP may be the first crucial step in efforts to 
improve cognitive abilities of older adults.  Given that multiple studies have shown music experience is strongly associated with better CAP
58-61, it is likely that pi[INVESTIGATOR_236199], leading to better cognition  (See 
Pi[INVESTIGATOR_236200]).  
Theoretical Background.  We hypothesize that improving brain function at early perceptual levels (i.e., 
CAP) may be optimal to attenuate cognitive and functional decline and potentially curb dementia prevalence.  This premise is grounded in the information degradation
8 theory.  The information degradation theory8, 62 posits 
that age- related ch anges in the brain cause i nitial sensory/perceptual processing errors that lead to difficulties 
with downstream information processing (i.e., CAP) and cognition (i.e., memory/executive function).  Accor d-
ing to this and similar theories, neurophysiological decline leads to reduced brain efficiency such that the speed and/or quality of processing (e.g., fidelity of representations, speed of neural transmission) is impaired due to poor perceptual encoding.  Thus, cognitive interventions should target improving initial pe rceptual proces sing 
(i.e., CAP) such that cognition can improve
63.  Accordingly, cognitive interventions that target basic perceptual 
processing may be most effective.  Furthermore, cognitive gains will be mediated by [CONTACT_236288] p-
tual processing (i.e., CAP).  Our recent analyses support this assertion, indicating that intervention targeting perceptual processing is more effective to curb dementia prevalence than other approaches
64.  The proposed 
study will advance the field by [CONTACT_236289] a mechanism of pi[INVESTIGATOR_236185].  
Pi[INVESTIGATOR_236201].  Engagement in learning challenging new skills, such as learning to play the 
pi[INVESTIGATOR_236202] , is a promising cognitive intervention approach that is likely more effective than cognitive 
stimulation65.  Pi[INVESTIGATOR_236203]-
cludes technique (scales/arpeggios/chords), music theory, and pi[INVESTIGATOR_236189].  Verghese et al. observed that older adults who reported playing musical instruments were 69% less likely to develop dementia
66.  Increasing  
neuroscience evidence ind icates positive, longitudinal associations of music training with e nhanced structures 
and function in the brain67, 68.  Thus, music trainin g (pi[INVESTIGATOR_236185], in particular) has been proposed as a viable 
means to attenuate age-related cognitive decline69, 70.  Pi[INVESTIGATOR_236204]-
tion because it requires the simu ltaneous coupling of sensory processing, motor skills, and complex cognitive 
operations to be execu ted with temporal precision71.  We propose that pi[INVESTIGATOR_236193] a promising cognitive 
intervention be cause:  
a- Pi[INVESTIGATOR_236199].  Our central premise is that improving CAP ma y be the first crucial 
step to augment older adults’ cognition.  Numerous studies ins dicate that music experience is strongly associat-
ed with better CAP ( e.g., 58, 59-61).  CAP is likely enhanced by [CONTACT_21173][INVESTIGATOR_236205]-
mands on complex temporal, sequential, and sensorimotor processing.  Correl ational studies indi cate superi or 
CAP for adults with formal music training compared to non- musicians72-74.  Further, Co -I Lister’s studies show 
that adult musicians have enhanced CAP, indicated by [CONTACT_236290], than their 
nonmusician counterparts9, 75.  Similarly, older musicians do not show age- related neural  timing del ays, indica t-
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 10 of 58  
 ing better CAP76.  Zendel and colleagues also demonstrated that CAP (i.e., auditory processing speed and 
speech -in-noise perception) is less suspectible to age- related decline in musicians59.  We propose to experimen-
tally examine the effects of pi[INVESTIGATOR_236206]’ CAP in a RCT.   
b- Pi[INVESTIGATOR_236207].  Epi[INVESTIGATOR_236208] c 
training is a ssociated with enhanced structures and function of the brain.  Scientists have hypothesized that pi-
ano training engages frontostriatal cerebellar circuits, including the motor cortex and basal ganglia, and will 
thus result in cognitive impro vements among older adults71, 77, 78.  Resear ch demonstr ates that long -term pi[INVESTIGATOR_236209], an area associated with higher cognition (e.g., 
executive function)79.  Pi[INVESTIGATOR_236210] e-
as of the brain than non- musicians79.  Neuroimaging research indi cates speci ficity in struc tural brain differences 
subsequent to pi[INVESTIGATOR_236185]80.  Giv en that pi[INVESTIGATOR_236211]-
tures and function, it may attenuate age- related cognitive decline.  
c- Pi[INVESTIGATOR_236212].  Pi[INVESTIGATOR_236213]-
mance81, 82, 83-85.  Hanna-Pladdy and Gajewski demonstrated that as compared to non- musicians matched on age 
and education, older adult musicians performed better on memory (letter number sequencing, verbal learning 
test ds=0.47-0.53) and executive function measures (phonemic fluency d =0.59)86.  Musical training was a 
stronger predictor of older adults’ cognitive pe rformance than lifestyle activities87.  Seinfeld an d colleague s 
found that older adults randomized to pi[INVESTIGATOR_236214] ( d=0.71) and execu-
tive function ( ds=1.70-1.85)67.  Co -I Bugos published two pi[INVESTIGATOR_236215].  I m-
provements in speed of processing were sustained three months after training (for details, see Preliminary 
Studies -Pi[INVESTIGATOR_236216]).  Combined with our pi[INVESTIGATOR_799], these data demonstrate enhanced speed of 
processing and executive function among older adults subsequent to pi[INVESTIGATOR_236217]81, 82.  
d- Pi[INVESTIGATOR_236218]’ mood and quality of life.  In our experience, older adults are 
eager to participate in pi[INVESTIGATOR_236219].  Sei nfeld and colleagues 
found that older adults completing pi[INVESTIGATOR_236220], improved mood, and better quality of 
life67.  Pi[INVESTIGATOR_236221] a more enjoyabl e activity than  other types of cognitive intervention.  Further, pi-
ano training could be immediately implemented in the community if it is eff icacious.  
In summary, we chose pi[INVESTIGATOR_236222] a novel cognitive engagement approach that shows 
promi se to enhance C AP and cognition.  Although prior epi[INVESTIGATOR_236223]81, 82, 83-85, statistically powered experimental studies are lacking.  Thus, 
we propose to examine the efficacy of pi[INVESTIGATOR_236224] a pha se II randomized trial . Per Onken’s model of be-
havioral interventions, we are examining efficacy in a research setting1.   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 11 of 58  
 4 STUDY DE SIGN  
 
A randomi zed clinial trial ( RCT ) with two arm s (pi[INVESTIGATOR_236225] ) across two lev-
els of cognitive functioning (cognitively intact older adults with and without MCI) will be rigorously conducted over three proje ct years.   Potentially eligible participants will complete  telephone screening, in -person baseline , 
and if needed, a clinical  assessment  to diagnos e MCI , will be randomized to complete pi[INVESTIGATOR_5533]-  or music listening 
instruction , and will complete immediate post- training a ssessments.   This is a phase II trial to test the efficacy of 
a promising behavioral intervention (i.e., pi[INVESTIGATOR_236185]) in a research setting
1. 
 
5 SELECTION AND EN ROLLMENT OF PARTICIPAN TS 
5.1  Inclusion Criteria  
 Inclusion criteria will be:   
• aged 60 years or older  
 
• willingness to provide informed consent  
 
• willingness to complete up to 23 study visits at USF including attending in- lab interve ntion two t imes a 
week for  a three- month period with the goal of completing 20 sessions.  
 
• ability to speak and understand English 
 
• Montreal Cognitive Assessment score of 20 or higher (score 20 to 30 inclusive)  
 
• intact vision (binocular near visual acuity of 20/[ADDRESS_285981] near visual acuity 
chart)  
 
• adequate hearing acuity (no greater than a moderate hearing loss [ thresholds <70 dB HL] in the mid-
frequency range  [ 1000, 2000 Hz] in at least one ear as determined by a standard pure t one hearing eva l-
uation)  
 
• Music Reading Assessment score of 18  or lower (score 0 -18 inclusive)  
 
• ability to understand study procedures and comply with them for the length of the study in the tester’s 
opi[INVESTIGATOR_1649] (and other study personnel opi[INVESTIGATOR_236226] w ith participant, such as t he study physician)  
 
5.2  Exclusion Criteria 
 Exclusion criteria will be:   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 12 of 58  
  
• moderate or worse depressive symptoms (GDS short form score >=5)    
 
• previous participation in USF Cognitive Aging Lab or Music Research and Testing lab1 intervention 
studies  
 
• previous participation in 10 or more hours of a computerized cognitive intervention computer programs 
(e.g., Lumosity, Posit Science Brain Fitness, InSight, or Brain HQ; Lace, CogMed, CogniFit, Happy 
Neuron, Dakim, DriveSharp or Sta ying Sharp by A ARP programs)  
 
• currently enrolled in another research study 
 
• planning on being away for two or more weeks during the next five months (recruit later)   
 
• undergoing chemotherapy or radiation treatment or planning surgeries or other procedures requiring a n-
esthesia within the next five months (recruit later)   
 
• four or more years of formal music training  such as private lessons or group lessons on a specific i n-
strument  
 
• ability to read music on two or more of the following clef s: Treble clef, Bass cl ef, Alto cl ef 
 
• four or mor e years of playing any one musical instrument  
 
• currently practicing or participating in any music activities - such as music performance or m usic reading 
or music lessons  or music related courses  
 
• difficulty and pain in moving hands or finger s, or neuropathy (e.g., numbness or tingling)  affecting 
hands , which interferes with the ability to use a keyboard2, or tremor in either hand, or missing any fi n-
ger or portion of a finger  
 
• self-reported diagnosis of dementia , stroke , serious bra in injury or neurological disorder  
 
• diagnosed by a physician or nurse with a TIA that occurred within the last 18 months   
 
• inability or unwillingness to give written informed consent at baseline  
 
• Clinical Dementia Rating Scale score of 1 or greater  
 
• Clinic al diagnosi s of dementia o r other disorder that in the study physician’s opi[INVESTIGATOR_236227]  
 
 
1 Although the “Music Research and Testing Lab” was omitted from version 1, thi s criteria was included in telephone screening from 
the study onset.  Potential participants were excluded if they r eported prior participation in Music Research and Testing Lab studies.  
2 We added this clarification, “that interferes with ability to use a k eyboar d” to the screening process . 
 Keys to Staying Sharp 
  Version 2 
     08/08/[ADDRESS_285982] Alzheimer’s Inst i-
tute Community -Based Memory Screening program  and the Department of Psychiatry and Behavioral Neur o-
sciences Memory Disor ders Clinic  (MDC) to enroll partic ipants in the study.   
 
Recruitment  and enrollment  will occur across  a pi[INVESTIGATOR_236228] .  Pi[INVESTIGATOR_236229].  Any changes to the protocol will be noted with the effective date and jus-tification.    Throughout the study period at least one Research Assistant in the Co gnitive  and Neurophysiology of  Aging 
Lab will ma ke recru itment phone calls and answer  potential participant emails/calls.  Individuals who have e x-
pressed interest in our research will be telephone screen ed (i.e., inclusion/exclusion que stionnaire) by l ab staff.  
The study script should be followed for describing the study and answering any participant questions.  Scree n-
ers will emph asize to the participants that they are committing to complete up to 23 in -person study visits (i.e., 3 
testing sessions and 20 inte rventi on sessions) over the next five months.  Once eligibility and interest has been 
assessed, the final outcome is  coded .  The final recruitment outcome will be coded as 1) Scheduled; 2) Not 
Scheduled and Will Not Try Again; or 3) Not Scheduled, Wil l Try Again.  
 If the parti cipant is not eligible because they are  planning on being away or unavailable for more than [ADDRESS_285983] for study pa rticipants.   
 
Those deemed initially eligible from telephone screening will c omplete an in -person scree ning at the Cognitive 
and Neurophysiology of Aging Lab.  This in- person screening will include the Montreal Cognitive Assessment  
(MoCA), Geriatric Depression Scale, vision and hearing screenings as well as the Music Reading A ssessment 
(MRA) to further conf irm eligibility  (See Inclusion/Exclusion above for details) .  
 Those potentially eligible  based on completion of these measures  will further complete baseline co gnitive, CAP, 
and everyday functional measures .  
 Those eligible who score 2 6
3 or better on the  MoCA will be enrolled in the study and referred to the study c o-
ordinator for randomization.   
 
Those  potentially  eligible w ho score between 20 to 25 on the M oCA  who were not referred by [CONTACT_236291] a clinic al evaluation v isit.  A cut -point of 20- 25 on the MoCA is indicative 
of probable MCI, while less than 20 is suggestive of dementia88.  
 
 
 
3 The MoCA cutpoint  was changed from 27 to 26 to use the more traditional and accepted value for impairment. Those who score be-
tween 20 to 25 will complete the clinical evaluation, rather than those who score 20 to 26.  
 Keys to Staying Sharp 
  Version 2 
     08/08/[ADDRESS_285984] MCI or dementia. The clinical evalu a-
tion visit will include subtests of the National Alzheimer’s Coordinating Center Uniform Data Set (NACC ) neu-
ropsychological battery and an exam by a study physician.  Subtests of the NACC battery will be used to dete r-
mine MCI status and exclude dementia.  The NACC battery subtests to be administered include the Clinical 
Dementia Rating Scale, the Multilingu al Naming Test,  the Benson Complex Figure Copy immediate and de-
layed subtests, the Craft Story [ADDRESS_285985]. 
 
An excepti on to the above procedure will be for patients with MCI who were referred from the USF Health 
Memory Disorders Clinic (MDC) or a study physician who have already undergone clinical evaluation in the past [ADDRESS_285986] that the participant comple te a releas e of medical 
records.  If we do not r eceive medical records by [CONTACT_236292], and the study physician recommends  it, 
we may  draw blood and order lab tests that may include : 
• CBC  
• Metab olic panel  
• Thyroid Stimulating Hormone  (TSH)  
• B12 
• D 
• Folic Acid  
 Any results not within normal limits will be reviewed by a study physician  and communicated to the participant .   
 Those without any clinically significant abnormalities  that would likely interfere with their ability to benefit 
from interventio n
[ADDRESS_285987] will explain the study procedures, offer to read the consent form to the participant (and will do so, if de-sired), answer any questions, and obtain informed consent.  A flow chart that details the study visits and tim e-
line will be provided to the participant to help explain the study procedures.  Participants will be encou raged to 
take time to consider whether they wish to pa rticipate in the study.  The person obtaining consent will leave the 
room to provide the parti cipant time to read and consider the informed consent statement.  The parti cipant will 
be provided an opportunity to ask que stions prior to signing the consent (as well as throughout the study).  A 
copy of the consent form will be provided to the partici pant.  
 
 
4 We ad ded “and communicated to the participant”, and we added the clarification, “that would likely interfere with their ability to 
benefit from i ntervention”.   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 15 of 58  
  
All signe d consent forms will be kept in a locked filing cabinet separate from the data to ensure conf identiality.  
In the data quality control process, each consent form will be reviewed to ensure accurate completion and pr o-
tocol adherence.   
 
• Infor med consent wil l be an agreement between the investigators and each participant having the capac i-
ty to understand and make an informed decision.  Consent will be obtained prior to each potential parti c-
ipant’s particip ation in this study.  
 
• Each individual participating in this study will be made aware of the fact that his or her participation i n-
volves research and the intent of the research, the expected duration of their participation and a descri p-
tion of the proc edures that will be followed.   
 
• Each parti cipant will be made aware of the reasonably expected benefits he or she might r eceive, as well 
as any risks or potential discomfort that are involved.   
 
• Each participant will be made aware of alternative procedures that are available to him or her.   
 
• Each participant w ill be made aware that his or her records will remain confidential, but that the NIH, 
IRB, and OHRP have the right to inspect his or her re cords.   
 
• Each participant will be told that his or her participation in the clinical study  is volunta ry, without for ce 
or influence from the inve stigators or research staff.  
 
• Each participant will be given the name [CONTACT_236343][CONTACT_236293](s) to answer 
his or her questions about the research and in the unlikely event of r esearch -related i njury.  
 
5.5  Describe the procedure for obtaining intervention group assignment  
 
The s tudy coordinator with the statistician will randomize participants stratified by [CONTACT_236294] .  Participants 
with and without MCI will be randomized in a 1:1 r atio to either pi[INVESTIGATOR_236230] .  To ensure balance throughout enrollment, randomization will be stratified by [CONTACT_236295] (present vs. absent) and conducted in varying blocks of participants as designed by [CONTACT_15957] -I Ji.  Dr. J i will 
generate the stratified permuted random blocks using R.   [CONTACT_236345] will maintain the random seed and the computer codes and will send the randomization list to the clinical trial coordinator.  The treatment allocation will be  de-
noted as  A or B and rec orded on the randomiz ation form by [CONTACT_236296].  The study coordinator 
will control access to the randomiz ation list and know whether A (B) stands for intervention (control).  Study 
investigators Edwards, Lister , and Andel  will remain blind to participant condition.  The testers will remain 
blind to participant condition. The trainers (including Co- I Bugos) and clinical trial coordinator will be aware of 
participants’ randomized condition.   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 16 of 58  
 5.6  STUDY INTERVENTIONS  
5.7  Interventions, Administra tion, and Duration  
 
There are two arms in this study including group pi[INVESTIGATOR_236185] (intervention) and music listening instruction  
(active control) .  Both of these arms are described to participants as “music training”.  The detai led procedural 
protocol for both training arms can be found here:  P:\ CBCS \CSD CAL \Study 15 Music Training NIA\ Trainer 
Docs \Study 15 Music Training Procedure Protocol…. or upon request to the PI.   
 The content protocol for the pi[INVESTIGATOR_236231] P: \CBCS \CSD CAL \Study 15 Music Train-
ing NIA\ Trainer Docs \Pi[INVESTIGATOR_236232]_JB_Copyright_2018.docx or upon request to Co-I Bugos. 
 The content protocol for the music listening instruction  arm can be found here P: \CBCS \CSD CAL \Study 15 
Music Training NIA\T rainer Docs \Mus ic Listening PowerPoints.zip  or upon request to the PI .   
 
Participants will be scheduled by [CONTACT_236297] -lab intervention phase sessions in 
groups of up to 10 individuals by [CONTACT_236298].  We are limited to 10 persons per class due to the phys-ical space available for the music listening condition.  The pi[INVESTIGATOR_236233] 10 participants in a group intervention session.  Scheduled  participan ts 
will be sent an appointment letter with directions and a map (by [CONTACT_236299] 8 or more days, by [CONTACT_236300] 7 days).  Participants will be reminded one to three days prior to the first intervention visit by 
[CONTACT_165367] a Research Assistant.    
 Both conditions will attend training two times a week for [ADDRESS_285988] regardless of intervent ion adherence.  We will code partici-
pants as completing training if 16 or more sessions are completed (16 to 20 sessions inclusive).  All training sessions must be completed within [ADDRESS_285989]- intervention assessment within 2 -60 days of their final in- lab inte r-
vention session (i.e., training completion date), or within [ADDRESS_285990] enhancing or maintaining cognitive abilities will not be allowed.  This includes computerized cognitive tr aining or stimu lation exercises aimed at cou ntering cognitive 
decline.  Participants will be instructed not to participate in such activities during the entire study period.  Fo r-
mal music training, such as private music lessons or group music cl asses  or courses related t o music (as exam-
ple voice instruction or musical instrument instruction  or a music appreciation class ), outside of the assigned 
activities will not be allowed.  Individuals who participate in such interventions will be dropped from the study.  
 
 
5 The following sentence s were omitted:  Each of the conditions will have a textbook and will  be ass igned weekly  homework.  Partici-
pants will be asked to report the amount of time they spend outside of class completing such activities.  
 Keys to Staying Sharp 
  Version 2 
     08/08/[ADDRESS_285991] 80% of the assigned sessions (at least  16 of 20 
sessions ).  The Research Assistant Trainers will record dates that participants attended in -lab training.  Partic i-
pants will be allowed up to [ADDRESS_285992].   
 
Primary d ata analyses wil l be intent -to-treat.  Sen sitivity analyses will further examine effects of  pi[INVESTIGATOR_236234]  (i.e., who completed 16 or more hours)  in both 
condi tions.   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 18 of 58  
 6 CLINICAL AND LABORATORY EV ALUATIONS  
Schedul e of Evaluations 
Evaluatio n Measure 
type Telephone  
Screen ing 
(≤ 60 days)  Baseline  Clinical Evalu a-
tion 
(≤ 45  days)  Randomiz ation 
<[ADDRESS_285993]  
>2 days 
and <=60 
days  
Informed Consent R  X     
Inclusion/Exclusion Questionnaire I/E X X X   X 
Geriatric  Depression Scale (GDS)  I/E, C   X     
Demographic Data  C  X     
Montreal Cognitive As sessment (MoCA)  I/E, C   X     
Memory Screening History IV  X     
Hearing and vision screening  
Pure-tone Hearing Thresholds 
Speech Recognition Threshold 
Near Visual Acu ity 
 I/E, C 
 X 
   X 
Music Reading Assessment  I/E  X     
Central Auditory Processing  
Time Compressed Speech 65% Words- in-Noise Test  
Dichotic Digits Test Dichotic Sentence Identification test  
ATTR  O 
 X 
   X 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 19 of 58  
  
Evaluation  Measure 
type Telephone  
Screen ing 
(≤ 60 days)  Baseline  Clinical Evalu a-
tion 
(≤ 45 days)  Randomiz ation 
<[ADDRESS_285994]  
>2 days 
and <=[ADDRESS_285995] 
Digit Coding 
Verbal Fluency  
- BHR, Clothes/ Girls’ Names, Veget ables/ 
Musical Instruments ( baseline) 
- FAS, Animals/ Boys’ Names, Fruits/Furniture ( post- test) 
 O 
  X 
     X 
Everyday Functional A ssessment  
Timed IADL Test  
Test of Everyday Attention 
 O 
 X 
   X 
Questionnaires  
Health Questionnaire  
Medication Audit 
Health Changes  SC   
X X     
  
X 
Adverse Events  R  X X  X X 
Clinical Evaluation  
NACC assessments:  
-Clinical Dementia Rating Scale  
-Craft Story [ADDRESS_285996] 
-Functional Assessment Scale  
-Clinician Diagnosis form  SC 
  X 
   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 20 of 58  
  
Evaluation  Measure 
type Telephone  
Screen ing 
(≤ 60 days)  Baseline  Clinical Evalu a-
tion 
(≤ 45 days)  Randomiz ation 
<[ADDRESS_285997]  
>2 days 
and <=60 
days  
Lab Asses sments (upon IRB approval ) 
CBC  
Metab olic panel  
Thyroid Stimulating Hormone (TSH)  
B12 
D Folic Acid  
MRI (if funding acquired)  IV   X    
Randomization IV    X   
Advanced Measures of Music Audiation 
(AMMA) - Day 1 of Training  E     X  
Basic Pi[INVESTIGATOR_236235] (BPM) OR  
Music Listening Me asure (MLM) - At d ays 1 
and 20 of t raining  E     X  
General Self -Efficacy and Music Perfo r-
mance Self -Efficacy ( At days 1 and 20 of 
training ) E 
    X  
Intervention sessions   C     X  
NICT Expectations Questionnaire (Between 
days 17 and 20 of training)  IV, C     X  
Tester blinding assessment IV      X 
C=covariate, E=exploratory, I/E=inclusion/exclusion, IV=internal validity, O=outcome, R=regulatory, SC=sample characterization   
 21 Keys to Staying Sharp 
  Version 2 
 
 
Page 21 of 58  
 6.1  Timing of Evaluations  
 
Prior to Randomization: The baseline visit should be scheduled within [ADDRESS_285998] be completed prior to the training content being administered.  It will be allowable to administer any of the aforementioned measures that are missing from the baseline or clinical visits after ra n-
domization, but administration will not be allowed once the participant has received any pi[INVESTIGATOR_236236] n-
ing trai ning.   
 Prior to Training Content:  Any biomarker assessments must be completed prior to training content (blooddraw, 
mri, etc.).  The g eneral and m usic self efficacy measures can be administered  at either baseline or  after rando m-
ization on day [ADDRESS_285999] be administered before 
training content is delivered.  If any of the aforementioned baseline, clinical, or pre -training  measures  are ad-
ministered after the training content began, a protocol deviation will be noted.  Such measures  will be coded as 
missing and will not be used in analyses.   
 Intervention Content:  The AMMA should be administered on day [ADDRESS_286000] occur within 18 weeks of bas eline if 
no intervention was  completed, or within 60 days of training completion date  (>= 16 sessions completed) .  Par-
ticipant post -tests will be conducted after the intervention phase for those who complete between 1 -15 sessio ns. 
6 
 
 
 
6 The sentence “Participant post -tests will be conducted after the intervention phase for those who complete betw een 1-15 sessions” 
and “ (>= 16 sessions completed) ” was added for clarification.  
 [ADDRESS_286001] Content:  The  post -training general and music self -efficacy measures must be completed after all 
training content is delivered, but may be completed at the beginning of the post -test visit, if needed.  The post -
test assessments of CAP, cognition, and everyday functiona l measures cannot be completed until after a delay 
of at least 24 hours after the final intervention session (i.e., training com pletion date) .  The post -test assessm ents 
of CAP, cognition, and everyday function should ideally  take place within 2- 30 days  of the training completion 
date ( >= 16 sessions completed) .  The maximum window for post -test is that it must be completed within [ADDRESS_286002] ID number  will be assigned on the participants visit control sheet ( VCS ) by [CONTACT_236301].  Informed consent will be obtained at the beginning of the first -in person visit, the baseline visit.  
Participants will be provided a flow chart that explains all of the study visits, duration of the visits, and the ti m-
ing of the visits during the consent process.  At the baseline visit, participants will complete the MoCA, GDS, hearing, and vision screenings , and MRA  to determine eligibility .  Those n ot eligible due to MoCA, GDS, hea r-
ing or vision scores will be referred to the appropriate professionals for treatment.  Additionally, participants for whom outer or middle ear pathology is indicated through otoscopic examination will be referred to an otolary n-
gologist or other professional and will not continue in the study.  Those participants who are eligible will be e n-
rolled in the study and will further complete thorough assessments of CAP , cognition, and everyday function.  
A questionnaire assessing  health  will be completed.  Research Assistant Testers who will remain blind to partic-
ipant condition will complete these assessments.  Participants will be referred to the s tudy coordinator  for ra n-
domiz ation.   
 If the participant meets eligibility criteria , was not referred from the MDC  or a study physician, but scores be-
tween [ADDRESS_286003] within 45 days after  the baseline visit.  
 
6.1.2 Interventi on Phase  
 Within three weeks of baseline  or clinical evaluation  phase completion  for each replicate, the  Clinical Research 
Coordinator and/or  Research Assistant Trainers will randomize enrolled participants in co llaboration with [CONTACT_236345]  
and schedule the ir first intervention visit.  Participants will complete rando mized exercises in groups of up to 10 
individuals at in -lab sessions that are 90 minutes  in duration, occur ring two times a week over the subsequent 
~3 months .  The goal will be for 95% of the training sessions to be conducted in groups of 3- [ADDRESS_286004] visit. Fidelity will be assured as described below (See Quality A s-
surance below ). 
 
At the first training sessions the trainers will administer the A dvanced Measure of Music Audiation (AMMA) , 
General Self -Efficacy Fo rm, and the Music Performance Self -Efficacy form .  Those in the music listening con-
trol group will complete the music listening measure while those in pi[INVESTIGATOR_236237].  The training protocols detail all of the procedure s and content  protocols detail  the training arms.  
Please see: P:\ CBCS \CSD CAL \Study 15 Music Training NIA \Trainer Docs \Study [ADDRESS_286005]  ques-
tionnaire to examine participants’ attitudes and expectations about the  potential effects of the  intervention  com-
pleted .  If a participant does not complete this questionnaire during the intervention phase, it may be completed 
at the begin ning of the post -test visit.   
 At the participants’ last training visit, the  self efficacy measures will again be completed, and the trainer will 
verify that participants learned basic musical concepts and skills introduced in the program with at least 70 % 
accuracy .  If participants score less than 70% correct on the Basic Pi[INVESTIGATOR_236235] (for pi[INVESTIGATOR_236190]) 
or Music Listening Measure (for music listening condition), as applicable to randomized condition, at their last scheduled training session a nd if they have  completed  less than [ADDRESS_286006] for up to 60 days after the training completion date ( >=16 sessions com-
pleted) or [ADDRESS_286007] Timeline  
A detailed and up- to-date field schedule will be maintained to indicate the dates of each phase of the study for 
each of the pi[INVESTIGATOR_236238].  This sched ule can be located at P: \CBCS \CSD CAL \Study [ADDRESS_286008] two weeks between completion of the baseline/clinical phase and beginning of 
training phase to allow for randomization, scheduling, and coordination of intervention phase.  The training phase wil l be 10- [ADDRESS_286009] for up to 60 days after training 
completion date (or [ADDRESS_286010] baseline if intervention was not com pleted).   
 
6.3  Intervention Discontinuation Evalu ations Retention  
 A CONSORT chart wil l be completed at the end of the trial.  Participant status (e.g., screened,  enrolled, refused, 
ineligible) will be recorded at each assessment.  Reasons for ineligibility will be doc umented.   
 We will employ an  inten t-to-treat design  as detailed in secti on 9.5 below .  Participants  who discontinue inte r-
vention will be encouraged to complete study visits and we will make every eff ort to follow and evaluate all 
enrolled  partic ipants.  
 
6.3.1 Retention  
 We will employ several methods to encourage participation.  In  the consent process, we will stress that enro l-
ling in the study involves a commitment to complete up to 23 in pe rson visits: [ADDRESS_286011] intervention (i.e., training)  session.   
 We will indicate for each participant the best manner (e.g., emai l, phone, cell) and times to contact [CONTACT_236302] f a-
cilitate communication.  We will also ascertain information for a secondary contact [CONTACT_236303] r-
ticipant to facilitate follow -up.  Such secondary contact [CONTACT_236304] a pproached if we lose contact [CONTACT_236305] a letter after repeated attempts over a 90- day 
period.    At the first in -lab intervention visit, pa rticipants will complete a statement indicating their commitment to co m-
plete  training sessions two times a week  in order to complete 20 sessions.  The statement  will be signed by [CONTACT_236306] a witness.  For any planned absences, an alternative make -up session will be scheduled.  Typi-
cally in -lab intervention sessions are of fered at regular times on Tuesday, Thursday or Monday, Wednesday, 
with make -up sessions scheduled on Friday.  However, every ef fort will be made to accomodate participants’ 
schedules  (e.g., offering Saturday training sessions) .  The trai ners will provide a  schedule of in -lab training at 
the first intervention study visit.  In week [ADDRESS_286012].   
 Participants who miss an in -lab training session unexpectedly (i.e.,  without having a make -up session sche d-
uled) will be contact[CONTACT_236307] [ADDRESS_286013] with the enrolled study participant 
with no response to phone calls or a letter after repeated attempts over a 90 -day period.   
 If participants are finding it difficult to attend the in -lab sessions, we will allow  up to t hree sessions of training 
to be completed each week  (1 session per 24 hours) until the intervention phase has ended or [ADDRESS_286014] within 45 days of baseline, if possible.  Parti cipants will be reques t-
ed to bring an informant (a relative or spouse or close friend who has regular contact [CONTACT_236308] r e-
port on their eve ryday activities ).  The informant will provide assent to participate in the study.  We will allow 
informant s to be interviewed by [CONTACT_756], if unable to attend in- person.  An evaluation will be performed by a 
qualified clinician  to determine/confirm a  diagnosis of MCI or dementia .  After the participants complete 
NACC assessments, study physicians will evaluat e the par ticipant at the end of the clinical evaluation visit.  The 
study physician will complete the Clinical Dia gnosis Form and determine eligibility.  
6.3.[ADDRESS_286015] size of d= 0.[ADDRESS_286016] one of the cognitive outcomes measures (verbal fluency, Tra ils, Digit 
Coding) relative to controls , we will randomize the remaining participants to 25 sessions (i.e., 37.5 hours)  in-
stead of  20 sessions ( i.e., 30 hours ) of training.  
6.3.5 Measures  
• Eligibility will be assessed in -person by [CONTACT_236309], hearing, cognitive status  (MoCA) , 
Music Reading Assessment (MRA),  and depressive symptoms  (GDS) .  These variables and 
demographic information may also be considered as covariates  in analyses .  
 [ADDRESS_286017] procedures ( American Speech -Language-
Hearing Association. (2005). Guidelines for manual pure-tone threshold audiometry  [Guidelines].  
Available from www.asha.org/policy .) and calibrated equipment from the USF Hearing Clinic.  
Otoscopic exam will be performed prior to inserting ear phones for pure tone testing. Pure tone 
air conduction thresholds in dB will be measured at 250, 500, 1000, 2000, 4000, 6000, and [ADDRESS_286018], these thresholds will be re -measured only if the participant reports a 
noticeable change in hearing since baseline testing (per Health Changes Checklist ).  Prescription  
for, use of (e.g., hours per day), and type of hearing aids will be recorded  for each  ear. 
o Speech Recognition Threshold (SRT) will be assessed using standard procedures ( American 
Speech -Language-Hearing Association. (1988). Determining thr eshold level for speech  [Guidelines]. 
Available from www.asha.org/policy .) and calibrated equipment from the USF Hearing Clinic.  
An SRT will be measured for each ear.  At post- test, these thresholds will be verif ied and presen-
tation levels of all auditory tests will be adjusted if the SRT in either ear varies by [CONTACT_726] +/ - 
5 dB.  
o The Montreal Cognitive Assessment (MoCA) will be used to examine participants’ cognitive st a-
tus 88.  This assessment has go od internal consistency, Cronbach’s α=.83, and test -retest reliabi l-
ity, r =.92 88.   
o The Geriatric Depression Scale (GDS) will be used to screen depressive symptoms.  The GDS 
has 92% sensitivity and 89% specificity to detect depression and has good test- retest reliability 
of r=.75-.81 90, 91.   
o Music Reading Assessment (M RA) 92 consists of a 40- item measure of basic music reading abi l-
ity with 20 treble clef items and 20 bass clef items.  
 
• Outcomes  include binaural central auditory processing ( CAP ) measures of : Time Compressed Speech 
65%, Words- in-Noise, Dichotic Digits Test, Dichotic Sentence Identification, and Adaptive Tests of 
Temporal Resolution.  If any participant expresses discomfort with the presentation level, it will be a d-
justed to a comfortable level.  The presentation level is recorded for each measure. 
 
o Time Compressed Speech Test (TCS).   The TCS test assesses both auditory temporal pro-
cessing and degraded speech understanding.  It is a word recognition task in which the timing 
feature of the speech is digitally manipulated to resemble rapid speech  93, 94.  TCS performance 
worsens with age 95.  Auditec Recordings Northwestern University Auditory Test Number 6 re c-
orded sentences (e.g., “Say the word jug”) are available at both 45% and 65% compression (65% is faster).  The listener must repeat the last word (test item), after the introductory sentence “Say the word”, which preceeds every test item.  The talker is female and approximately 4 sec of s i-
lence separate the stimuli.  Participants are asked to repeat 50 words delivered through insert earphones at a level of 50 dB SL (re: SRT), and percent correct is calculated.  Normative data on time compressed speech performance in adults have been descr ibed elsewhere 
96.  For the pre sent 
study, only the 65% condition will be used. 
o Words- in-Noise Test (WIN).   The WIN is a test of degraded speech understanding or speech 
understanding in noise.  It was developed as an  instrument that quantifies the ability of  listeners 
to understand speech in background multi- talker babble 97.  The stimuli are the Northwestern 
University Auditory Test Number 6 monosyllabic words with a static preceding sentence (e.g., “Say the word road”) and a background of multi- talker babble.   The talker is female and appro x-
 [ADDRESS_286019]  lists are used; 5  words are presented at  
each of 7 signal -to-noise ratios ( SNRs ).  The SNRs are presented in a decending manner, from 
[ADDRESS_286020] of the sentence, ignoring the babble.  The WIN uses a modified  method of constants to 
establish the  SNR at which 50% correct performance is  achieved on the materials.  The 50% 
point is computed with the Spearman -Kärber  equation 98, 99 [50% = 26 – (#co rrect)(0.8); “0.8” is 
the attenuation step size (4 dB) divided by [CONTACT_236310] (5)].  The WIN has been 
established as a reliable measure (intra- class correlation coefficient = 0.88) 100, 101. 
o Dichotic Digits Test (DDT).  The DDT is a test of binaural processing that uses a closed set of stimuli (numbers), thus having a relatively low linguistic load.  The DDT consists of numbers between one and nine, excluding the two- syllable number seven ( r=.79-.97)
102.  Two numbers 
are presented to the right ear while two numbers are presented simultaneously to the left ear , for 
a total of four numbers.  The talker is male.  Approximately four seconds of silence separate each set of four numbers, and approximately one second separates the individual pairs within a set of four.  The participants are instructed to repeat all four numbers that were presented to them, in any order.  Twenty -five sets of four numbers each are presented, for a total of [ADDRESS_286021] out of the 100 numbers presented.   
o Dichotic Sentence Identification (DSI).  The DSI test is used to assess binaural speech unde r-
standing in competition and also falls into the broad category of degraded speech understanding.  The DSI stimuli are identical to those of the Synthetic Speech Identification Test (SSI)  
103, rec-
orded grammatically correct yet meaningless sentences (e.g., “Small boat with pi[INVESTIGATOR_236239]-come”).  Unlike the SSI, for the DSI a competing sentence is delivered to the contralateral ear.  The DSI is presented at a level of 50 dB SL (re: SRT) via insert earphones; the talker is male and approximately [ADDRESS_286022] reliability of the DSI is high in older adults, r  = .79 - .97.  Deficits in DSI perfo r-
mance may be predictive of cognitive decline 
104. 
o Adaptive Tests of Tem poral Resolution (ATTR).  The ATTR105 is a copyrighted and freely 
downloadable test of auditory temporal processing.  Details regarding the ATTR have been pub-lished previously
105-107.  Briefly, the ATTR is  used to measure gap detection thresholds using a 
three- interval, two -alternative forced -choice adaptive procedure targeting 70.7% correct gap d e-
tection.   The stimuli used to define the silent gaps are ¼ octave narrow bands of noise (NBN) 
centered on either [ADDRESS_286023] 
and target intervals are presented in random order, following the reference interval.  The partic i-
pant’s  goal is to select the target interval from among the standard and target intervals.  The pa r-
ticipant is not allowed to select the reference interval.  Two subtests of the ATTR were used in 
the present study, the within-channel subtest for which NBNs before and after the gap are both 
centered on [ADDRESS_286024] for which the NBN before the gap is centered 
on 2 kHz and the NBN after the gap is centered on 1 kHz.  The ATTR was presented at a high, 
comfortable level, self -selected by [CONTACT_236311]108.  Reliability for the 
ATTR has been established with intraclass r =.58-.[ZIP_CODE]. 
 28 Keys to Staying Sharp 
  Version 2 
 
 
Page 28 of 58  
 • Outcomes  also include c ognitive measures:   Verbal Fluency Test (phonemic fluency, category fluency, 
and category switching), Trail Ma king Test, and  Digit Coding  
o Verbal Fluency109.  Executive function will be assessed with phonemic , category, and category 
switching  verbal fluency tasks.  Phonemic fluency consists of three, one -minute trials during 
which the examinee names as many words as can be thought of that begin with a given letter, e x-
cluding proper nouns, numbers, and the same word with a different suffix will also be assessed 
(test-retest reliability=.88)110.  Categ ory fluency is designed to mea sure the speed and flexibility 
of verbal thought processes ( r=0.82; sensitivity=.88; specificity=.96)109, 111.  A switching condi-
tion is included that requires participants to alternate between sets (e.g. naming fruits and fur ni-
ture)  (r=0.51 ).  Different versions of this measure will be administered at baseline and post -test.  
The BHR, Clothes/Girls’ Names, and Vegetables/Musical Instruments will be administered at 
baseline while the FAS, Animals/Boys’ Names, and Fruits/Furnitu re version will be admini s-
tered at post -test. The recorded score is the number of correct items for each task.  
o Trail Making Test Part A.   Speed of processing is evaluated using the Trail Making Test Part 
A.  This test ( r=.53- .64), requires participants to draw a line connecting a series of numbers in 
sequential order (1- 2-3, etc)112.  The recorded score is the time required to complete the task113. 
o Trail Making Test Part B.   Executive function is evaluated using the Trail Making Test  Part B, 
which is a r eliable measure ( r=.54-.62) that requires participants to draw a line connecting a s e-
ries of number and letters in alternating, sequential order (1 -A-2-B, etc) (Strauss et al., 2006).  
The recorded score is the time required to complete the task113, 114. 
o Digit Symbol Coding .  Cognitive speed of processing is evaluated using Digit Symbol Coding 
109.  This test consists of [ADDRESS_286025] 
responses.  Lower scores indicate better performance.  Psychometric properties are reported in 
the manual.  
 
• Outcomes of e veryday function include the Timed IADL and TEA tests  
o Timed IADL  involves timed performance of five tasks encountered in daily life.  The pr eviously 
validated tasks115 utilize real -world stimuli and represent five IADL domains, including comm u-
nicati on (finding a telephone number in a phone book), finance (making change), cooking (rea d-
ing the first three ingredients on a can of food), shoppi[INVESTIGATOR_007] (finding two items on a shelf of pac k-
aged foods) and medication management (reading the directions on a medic ine bottle label).  
Scores are generated by [CONTACT_236312].  Task scores are combined into a single composite by [CONTACT_236313] z  scores 
computed for each of the five tasks after err or correction.   Test -retest reliability of the Timed 
IADL is r  = .[ADDRESS_286026] of Everyday Attention (TEA)116, [ADDRESS_286027] reliability of v ersions A to B range from .59 -
.[ZIP_CODE].  Four of the eight subtests will be administered in this study and include : 
 Visual Elevator.  Participants count up and down floors as they follow a serie s of vi sual-
ly presented doors and arrows.  An accuracy (how many final floor numbers the partici-pant gets correct out of 10) and timing scores (total time taken for the correct items) are 
 [ADDRESS_286028] measures atte ntional switching117.  
 Elevator Counting wth Reversal.   As with the Visual Elevator subtest, participants 
count up and down as they follow a series of visually presented doors.  I n this subtest 
however, the tones are at a fixed speed.   The recorded  score is the number of cor rect an-
swers out of [ADDRESS_286029] measures auditory -verbal working 
memory117.  
 Telephone Search.   Participants search  for symbols while searching for entries on a rep-
licated page of a telephone directory.  The recorded  score is the time per target score  
(number of correctly detected symbols divided by [CONTACT_236314]) and the scaled score.  This subtest measures selective attention
117.  
 Telephone Search While Counting .  Participants search the telephone directory while 
counting strings of tones simultaneously.  The recorded score is obtained by [CONTACT_22888] m-
bined performance on the Telephone Search and Telephone Search While Counting give s 
a measure of divided attention, as well as the scaled score.   This subtest measures sus-
tained attention117.  
 Exploratory measures   Exploratory mesures include a measure of music aptitude and two self- efficacy measures.   
 Advanced Measures of Music Audiation (AMMA) consists of [ADDRESS_286030] eliability for music majors is  r=.89 and non- music majors, r =.[ZIP_CODE].   
 
The General Self -Efficacy119 is comprised of 23 positive and negative items on a 14-point Likert scale ranging 
from strongly disagree (1) to strongly agree (14).  Internal reliability is established (α=.86-.71).  Items are de-
signed to reflect elements of effort, initiation, and persistence as described in Bandura’s social cognitive theory.  
 An adapted version of t he Music Performance Self -Efficacy Measure
120 will be used.  This questionnaire 
(α=.97)  consists of 24 items to which participants respond by [CONTACT_20683] a number (0–100) to reflect strength of 
agreement to a specific statement regarding musical beliefs (0 = strongly disagree … 100 = strongly agree).  
The items included are based on  Bandura’s sociocognitive theory and assess domains : mastery experiences 
(eight items), vicarious experiences (five items), verbal/social persu asion (six items), and physiological state 
(five items).  An example of an item from this measure is, “I have had positive experiences performing music in 
the past.” This measure has been used in studies with older adults121.  The adaptation from the original version 
includes a change in the order of the questions and changes in the wording of 7 questions.  More specifically, 
the question, “I have improved my music performance skills by [CONTACT_236315], who are sim i-
lar to me in some way, perform well”, was changed to “I have improved my music performance skills by [CONTACT_236316]-
ing professional musicians perform well”.  The question, “My friends think I am a good performer on my pr i-
mary instrumen t”, was changed to “My friends think I am a good performer on my pi[INVESTIGATOR_5533]”.  The question, “I 
have had positive experiences performing in large ensembles” was changed to “I have had positive experiences 
performing in large ensembles (more than 11 performers)”.  The question, “I have improved my music perfor-
mance skills by [CONTACT_236317], who are similar to me in some way, perform well” was changed to “I 
have improved my music performance skills by [CONTACT_236318] I know perform well (parent, brother, sister, 
church member, etc,)”.  The question “I have had positive experiences performing solo, or, in a small ensemble” 
was changed to “I have had positive experiences performing music solo”.  The question, “I have had positive 
 30 Keys to Staying Sharp 
  Version 2 
 
 
Page 30 of 58  
 experiences performing musi c in large ensembles” was changed to “ I have had positive experiences pefo r-
maing music in a small ensemble (2 -10 performers)”.   Lastly, the question “Performing with my instrument 
makes me feel good” was changed to “Performing on pi[INVESTIGATOR_236240]”.  
6.3.6 Questionnaires 
 
A health questionnaire will be administered at baseline to characterize the sample.  Participants are asked whether a doctor or nurse every told them that they any of the following conditions: arthritis, asthma and/or other breathing problems, cancer (other than skin cancer), chronic skin problems, diabetes, heart disease, heart problems (other than heart disease), high cholesterol, hypertention or high blood pressure, mood problems or anxiety, multiple sclerosis, osteoporosis, parkinson’s disease, stroke, TIA/mini-stroke within last 18 months, mild cognitive impairment or memory impairment, neuropathy, or any other significant illness.   Participants’ expectations  about the effects of intervention/control exercises on post- test outcomes  will be e x-
amined as a potential covariate.  During the last week of the inter vention stage, the Trainers will administer a 
modified version of the The Co gnitive Training Expectations questionnaire to examine participants’ attitudes 
and expectations about the effects of the intervention received  on cognition and everyday function
122.  The 
NICT questionnaire was modified to refer to “music training” or “pi[INVESTIGATOR_236185]”, and  the “memory” and “rea-
soning” questions were omitted sinc e we are not assessin g these abilities .  The quesionnaire explains that cogni-
tive function refers to abilities such as attention, memory, visual perception, information processing, and re a-
soning; and that cognitive training refers to activities that aim to  improve cognitive functions by [CONTACT_236319] 
a specific timeframe (i.e., several weeks or months).  The questionnaire then asks participants to rate what e f-
fects they expect the intervention exercises to have including whether the exercises will result in improved gen-eral cognitive function, memory, concentration, distractability, reasoning, multi-tasking, and everday perfo r-
mance.  Ratings are on a 7 -point Likert scale ranging from completely unsuccessful (1), to no expectations (4), 
to completely succes sful (7).  Participants also rate the degree to which the intervention was engaging, enjoya-
ble, and challenging on a 7-point scale ranging from very strongly agree (7), to neither agree or disagree (4), to very strongly disagree (1).  Finally, participants rate whether or not they were satisfied with the program rang-ing from extremely satisfied (7), to neither satisfied or dissatisfied (4), to extremely dis satisfied (7)  and indicate 
whether they felt that they had “trained their brain” (yes/no).  This questionnaire has been successfully impl e-
mented in others’ and our prior cognitive intervention studies.  
 At the baseline visit, a list of prescription  medications that the participants’  are taking will be recorded.  For 
those who score 20-[ADDRESS_286031] cognitive or functional performance.  Participants are asked if they expe-rienced any significant changes in health conditions such as head injury, chemotherapy or radiation treatment, heart attack or myocardial infarction, changes in vision or hearing, or underwent general anesthesia.  They are 
also asked if they had any new diagnoses of stroke, mini-stroke, TIA, heart disease or congestive heart failure, Parkinson’s disease, m ild cognitive i mairment or memory impairment, Alzheimer ’s disease, and Multiple Scle-
rosis.   
 31 Keys to Staying Sharp 
  Version 2 
 
 
Page 31 of 58  
 7 MANAGEMENT OF ADVERSE EVENT S 
We will track safety throughout the trial.  Participants will be queried as to whether or not they experienced any 
discomfort at the end of each study visit.  See Reporting of Adverse Event s below for further details. Data and 
safety monitoring will focus on participant recrui tment, data quality, and safety (confidentiality, minimization 
of risks, and surveillance for adverse events).  The study team will meet weekly to discuss the progress of the trial.  Details on adverse event monitoring and reporting are provided below .   
 An adverse event (AE) is defined as any unfavorable and unintended diagnosis, symptom, sign, syn drome or 
disease which either occurs during the study, having been a bsent at baseline, or if present at baseline, appears to 
worsen.  Adverse events are to be recorded regardless of their relationship to the study interve ntion.   
 Participants may experience fatigue or frustration  from completing the intervention exercises.  P rolonged sitting 
activity can result in muscle/joint soreness (e.g., wrist, elbow, fingers, hip flexors, neck, back , buttock), eye 
strain, muscle crampi[INVESTIGATOR_236241], or hea daches.  Any of these symptoms that increase in frequency and last 
more than [ADDRESS_286032] not been reported. 
 A serious adverse event (SAE) is generally defined as any untoward medical occur rence that results in death, is 
life threatening, requires inpatient hospi[INVESTIGATOR_8686], results in persistent 
or significant disabi lity/incapacity .  
 
8 CRITERIA FOR  PARTICIPANT  DISCONTINUATION  
 Participants who undergo  any surgical procedures requiring anesthesia, chemotherapy, or radiation during the 
study period will be excluded.  Parti cipants who exper ience a stroke, TIA, or head injury during the study per i-
od will be excluded.  Participants who complete any other cognitive intervention not a ssigned to them during 
the course of the study will be excluded.  In these situations, only data points collected prior to the event will be 
used in analyses.  If plans to undergo such events are  known, and 80% of assigned intervention sessions have 
been offered , an attempt to com plete post -test prior to the event  will be made.   
[ADDRESS_286033].  Participants may be followed longer with positive results and addi-
tional funding.   
9.2  Primary Objectives  
The primary and secondary outcome measures are detailed above.   
 32 Keys to Staying Sharp 
  Version 2 
 
 
Page 32 of 58  
 9.2.1 Primary outcomes  
• To examine the efficacy of pi[INVESTIGATOR_236242] i mprove CAP, cognition, and everyday function among 
older adults.  We will assess the effects of pi[INVESTIGATOR_236243], cognition, and everyday function.  
 
CAP includes Time C ompressed Speech, Words -in-Noise, Dichotic Digits Test, Dic hotic Sentence Identific a-
tion and Adaptive Tests of Temporal Resolution.  All are parametric tests of perception.    Cognition includes Verbal Fluency (phonemic, category, and switching), Digit Coding, and Trail Making test.  All are pa rametric tests of cognitive function.   
 Everyday function includes the Timed IADL test and Test of Everyday Attention both parame tric measures.  
Both measures will be examined individually.    Principal Component Analyses (PCA) wil l be performed with CAP , cognitive and functional  measures to form 
composites of outcomes  for use in analyses to reduce the number of comparisons. 
 Hypotheses: The pi[INVESTIGATOR_236244], cognition, and everyday function immediately post -intervention.  
Secondary Objectives  
 The secondary objectives are:  
 
• To examine the moderating effects of MCI on pi[INVESTIGATOR_236245].  Moderating effects of MCI status will determine if pi[INVESTIGATOR_236195]/or without MCI.  We do not have a directional hypothesis for this objective.  
 
• To explore mediators of intervention effects.  
 Hypothesis : Grounded in theory
[ADDRESS_286034] up to 20% attrition after the initial in -person visit across the time period in which cognitive interve n-
tion study protocols will be administered.  Our goal is to complete in -person screening visits for up to [ADDRESS_286035]  99 individuals randomized to each condi tion 
(pi[INVESTIGATOR_236185], controls)  to have adequate statistical power .  With stratified randomization, this will result in at 
least  48 persons per MCI/no MCI subgroup.   
 
 33 Keys to Staying Sharp 
  Version 2 
 
 
Page 33 of 58  
 Statistical power analysis using G*Power123 in consideration of our pi[INVESTIGATOR_236246] a s well as attrition  
was conducted to estimate power .  We will control type I error at .[ADDRESS_286036] 80% statistical power.   
 
To power Specific Aim 1: To examine the efficacy of pi[INVESTIGATOR_236191], cognition, and eve-
ryday function amon g older adults , a final n of 198 participants (n= 99 per randomized condition) will achieve 
95% power to detect a significant group x time interaction across baseline to immediate post -test, with an alpha 
of .05.  This assumes a small effect size ( f ) of 0 .[ZIP_CODE] (Cohen’s f  effect sizes are 0.10 - small, 0.25-  medium: f  is 
roughly equivalent to ½ of d when comparing two groups)124.  
 
To power Specific Aim 2: To examine the moderating effects of MCI on intervention efficacy, a final n of 
[ADDRESS_286037] medium effects ( f=.10) for significant group x time x moderator  
three way interactions. 
 
9.[ADDRESS_286038] and unbiased results, data will undergo a rigorous quality control process to ensure 
consistency in scoring, coding and accuracy of data entry.  Additionally, 20% of all data folders will undergo a random audit every replicate.  Also see D ata Management  procedures  and Quality Assurance  detailed below.   
 
9.[ADDRESS_286039]. Hudak, who 
is unblinded.  The Clinical Trial Coordinator will work with the IRB to decide if the study should be terminated 
early.    
 
Interim analyses will be conducted to ensure the feasibility of study intervention adherence.  If at interim ana l-
yses, less than 75% of participants randomized to an arm complete at least 16 sessions (80% of prescribed 20), the intervention arm will be deemed not feasible.  If this occurred for both arms, the study will end.   
 
Finally, interim analyses will examine the potential efficacy of  the pi[INVESTIGATOR_236247] .  Effect sizes  and conf i-
dence intervals  for all cognitive outcome s will be calculated for pre - to post - training relative to controls.  We 
expect that the pi[INVESTIGATOR_236248] d=0.[ADDRESS_286040] one of the cognitive  measures of verbal fluency (phonemic, ca tegory or switching), Trails A or B, or 
Digit Coding, relative to active controls.  If an effect size from pre - to post - training relative to controls of this 
 [ADDRESS_286041] the distribution of s cores to confirm that parametric 
statistical testing is appropriate.  In the event that distributional properties do not support parametric tests, we 
will compare the results from conventional parametric analyses with (a) results from similar nonparametric  
testing (e.g., Wilcoxon signed ranks test) , (b) results from parametric analyses co nducted after the non -normally 
distributed variables are transformed to improve normality to compare the results with the conventional par a-
metric analyses, and (c ) Any ille gal values or outliers of >= +/ -3z will be checked for accuracy with the raw d a-
ta. 
 Composite Outcomes.  Data reduction in the form of principal component factor analysis (PCA) will be used 
to derive composite outcomes of CAP ,cognition, and everyday functi on for analyses to reduce the number of 
comparisons.  Baseline data across CAP , cognitive , and everyday function outcomes will be factor analyzed u s-
ing pairwise deletions.  Based on the number of factors derived and factor loadings of the individual measur es 
(.4 or greater), outcome composite scores will be calculated  after transforming the  baseline data to z scores 
while  taking into account the directional scaling of the items.  Post -test scores will be standardized based upon 
the baseline mean and SD.  Th e baseline factors and loadings will be applied to calculate post -test composite 
scores .  
 Preliminary/Descriptive Analyses .  Prior to the analyses described below, we will conduct one -way ANOVA 
or Chi -square analyses as appropriate comparing the  randomized  groups  at baseline on age, race, education, sex, 
MoCA, GDS, hearing and vision, to ensure that the study randomization procedures were successful.  We will also confirm the equivalence of the two randomized conditions by [CONTACT_236320]-es.  The total across the six items relevant to cognition will be calculated and examin ed in analyses.   If even a 
marginally significant (p<.1) difference is observed for any of the se study variables, the  pertinent variables  will 
be included as covariates in subsequent analyses.  
 Specific Aim 1: To examine the efficacy of pi[INVESTIGATOR_236191], cognition, and everyday fun c-
tion among older adults .  We will compare changes in performance for pi[INVESTIGATOR_236249] (baseline, immediate post -test).  We will use the PCA -derived composites of CAP 
and cognition, and everyday functioning as outcomes.  We will use repeated measures analyses of variance within the mixed effects models, examining group as the between- subjects factor and time as the within -
subjects factor.  The group x time interaction will indicate whether the participants randomized to pi[INVESTIGATOR_236250] r elative to those randomized to the control  group.  This output will be ob-
tained for each of the composite outcomes (CAP, cognition, and functional abilities).  For aim [ADDRESS_286042] that some participants will not complete their intended  followup a c-
cording to the protocol for a variety of reasons, ge nerating missing values.  Intent -to-treat (ITT) analysis has 
become a widely accepted method for dealing with this issue.  To maximize available information, we will employ statistical techniq ues that allow for the inclusion of missing data.  Specifically, we will use linear mixed 
effects models to analyze data.  This advanced analytical method allows for the inclusion of participants with missing data, so long as data are missing at random and offers flexibility with regard to the specification of the variance/covariance structure, which often leads to improved fit of the analytical model to the actual data.   If 
there is  non- ignorable missing data, we will apply pattern- mixture mixed effects mo dels to assess the sensitivity 
of our findings with regard to missing data  
126.   
 Specific Aim 2: To examine the moderating effects of MCI on intervention efficacy.   We will also test for 
moderation effects to determine at what stage along the cognitive status continuum —without MCI vs. MCI —
intervention is most effective.  To do so, we  will examine th ree-way interactions (MCI  x training group x time) 
for the CAP, cognitive , and everyday function composites.  When an interaction is significant, we will stratify 
analyses by [CONTACT_236321] .  Effect sizes  from pre - to post - training relative to controls  will 
be compared for pa rticipants with/without MCI.  An alpha of .05 will be used for these analyses.  
 
Participants who score 26  or higher on the MoCA will be defined as no MCI (i.e., cognitively normal).  Those 
particip ants who score a 20- [ADDRESS_286043] 
performance at or 1 SD below the ir age, sex, and education norms  on any of the following measures:  Trails, 
Verbal Fluency, Digit Coding, Craft Story Recall, Multilingual Naming Test, or Benson Complex Figure.  
Those with MoCA scores 20- [ADDRESS_286044] change  of pi[INVESTIGATOR_236251], cogni tion, and everyday function for the sample overall as well as stratified by 
[CONTACT_236322] (80% or more of sessions completed) .  
 
 
Additional Analyses.  To address exploratory aim 3, with identification of significant eff ects from the analyses 
for aim 1, we will examine behavioral mediators of interventions to determine mechanisms.  We hypothesize that improved CAP will mediate cognitive gains .  We hypothesize that cognitive gains will mediate functional 
gains.  Formal med iation tests using a bootstrappi[INVESTIGATOR_236252]
[ADDRESS_286045] and total effects.  The procedure allows simultaneous estimation of all three pathways (M on Y; X on M; X on Y, where M=mediator (CAP score), Y=outcome (cognition), and X=predictor (group assignment)) as well as adjustment for covariates (e.g., depression).  The use of bootstra p-
pi[INVESTIGATOR_236253]
129.  An alpha of .[ADDRESS_286046] sensitivity analysis for missing data by [CONTACT_236323].  The pattern of results will be compared to ITT analyses.  Results will also be conducted after any outliers, defined as observations with va l-
ues of greater than +[ADDRESS_286047] sizes will be reported by [CONTACT_236324] (alpha .05).    Relevant to aim [ADDRESS_286048] -
change of pi[INVESTIGATOR_236254] (i.e., who com-pleted 80% or more of assigned number of sessions) in both conditions.  Analyses detailed above for specific aims [ADDRESS_286049] sizes.    Relevant to aim 1 and 2 analyses, w e will further examine if effects were moderated by a better ear pure-tone 
average (PTA).  In these analyses we will examine if there are significant training group x time x hearing inte r-
actions on CAP, cognition, or everyday function, using an alpha of .05.   
As it is possible that training will be differentially effective for those with CAP disorders (CAPD), we will ide n-
tify a subgroup of participants (regardless of MCI status) who could be diagnosed with CAPD.  Diagnosis of 
(C)APD requires performance deficits on the order of at least two standard deviations below the mean on two or 
more of the following tests39, 130:  temporal processing (TCS, ATTR), degraded speech understanding (WIN), or 
binaural processing (DDT, DST).  Analyses for the cognition and everyday function outcomes will be repeated with groups defined as with/without CAPD as an independent variable.  We will examine if there are significant training group x time x ADP status interactions using an alpha of .05.   We may also explore moderation effects of covariates such as MCI subtype (amnestic, non- amnestic, multiple 
domain) to determine who is most likely to benefit from the intervention among participants with MCI.  To do so, we will examine three -way interactions (covariate x training group x time) stratified by [CONTACT_236294], if MCI 
was a significant moderator in results of analyses for aim [ADDRESS_286050] sizes will be examined .    
 The self -efficacy measures (general self -efficacy and music performance self -efficacy) will be examined as ex-
ploratory outcomes by [CONTACT_236325] (be-fore/after training).  Analyses will include ordinal logistic regression analyses across levels of self- eficacy co n-
ducted within the generalized estimating e quations (GEE) statistical framework to account for repeated meas-
urements.  Significant improvements on either measures demonstrated in this analyses will be followed by [CONTACT_236326]-ploratory mediation analyses to examine if improve ments in self -efficacy can account  for any observed training 
 37 Keys to Staying Sharp 
  Version 2 
 
 
Page 37 of 58  
 effects on CAP, cognition, or everyday function.  Thus, we will examine an alternative hypothesis that training 
gains can be attributed to i mproved self -efficay.  An alpha of .05 will be used.  
 To ex plore  if initial music aptitu de affects performance within each of the training conditions, AMMA at bas e-
line will be examined as a covariate (i.e., modifier) of Basic Pi[INVESTIGATOR_236255] (BPM) from the first to the final day of training among those in the pi[INVESTIGATOR_236190].  Similarly, baseline AMMA will be e x-
amined as a covariate on the Music Listening Measure (MLM) across the same two time points within the co n-
trol group.  Again, ordinal logistic regression with GEE will be used given the ordinal scaling of the outcomes.  An alpha of .05 will be used.  
 38 Keys to Staying Sharp 
  Version 2 
 
 
Page 38 of 58  
 10 DATA COLLECTION, SITE MONITORING, AND ADVERSE EXPER I-
ENCE REPORTING  
10.1 Records to Be Kept  
 
A visit control sheet (VCS) will be the only document indicating the participants name [CONTACT_236344].  This data form will be kept in a locked filing cabinet separate from the study data.  This data form will be accessible to the Testers and Trainers as well as PIs, only.    Signed consent forms will be kept in locked filing cabinets separate from the data forms and will not contain the 
subject id number.   
 
We will keep all  completed  telephone screening interviews  to track the number of screenings completed, num-
ber scheduled , and reasons ineligible.  We will keep the  data forms completed and intervention re cords, which 
will contain subje ct id only, in a locked filing cabinet.    
 All documents will be kept for at least [ADDRESS_286051] -study close out (or longer if required by [CONTACT_236327]).   
  The study database will not include participant names or other identifying information.  When the study data are released for sharing, the data will be completely de -identified with any potentially ide ntifying information ( e.g., 
date of birth) removed.  
 
10.[ADDRESS_286052] a folder with participant id for all assessments completed for each study visit and for the intervention phase.  Every data form (page) will include the participant id and date the form was administered.   
 Origin al versions of the data forms arranged by [CONTACT_236328] a locked filing cabinet in the lab noted 
with an  electronic file location in the footer.  Data forms will only be copi[INVESTIGATOR_236256].  Each 
testing visit will include a detailed checklist of all measures to be administered and procedures to be followed, which will be initialed by [CONTACT_236329].   
 Immediately after completing a participant visit, the tester will score the asses sments and check all forms for 
comp letion, a nd within [ADDRESS_286053] step of our data quality control pr ocess.   
 
 39 Keys to Staying Sharp 
  Version 2 
 
 
Page 39 of 58  
 At the end of each testing visit and inte rvention phase , every data form will be reviewed in a five -step quality 
control audit (scoring, rescoring, entry, checking, reconciling) with each subsequent step performed by a diffe r-
ent Research Assistant.   
 The data will be entered into a custom -designed MS Access database that uses MS SQL Ser ver as the back end 
relational database and completely integrates study management (e.g., create forms, collect data, generate r e-
ports, prepare for analysis).  The database is designed to ensure access co ntrol, audit control, data integrity, user 
authentication, and transmission security.  The data quality control and custom database function to minimize missing data and e nsure data integrity.   
 Only individuals trained by [CONTACT_978] [INVESTIGATOR_236257].  Reports 
reflecting entered data will be printed for each testing visit of each participant  upon da ta entry .  The data report 
will be checked for accuracy with the raw data by a trained  staff member other than who entered t he data.  E r-
rors or omissions will be returned for reconciliation and the pr ocess will be repeated until  the entered data are 
deemed error free.  Additionally, a ra ndom audit of 20% of folders entered will be completed each replicate.   
[ADDRESS_286054] annually t o review/monitor any adverse events, if they occur .  The study i nvestigators may  
also meet monthly in the final quarter of the study to complete data analysis, interpretation, and publ ication.   
 All study staff will read, be instructed in, and may be asked to pass a certification exam on the study pr otocol 
before working on assigned study activities.  All study staff will be required to complete IRB Human Subjects training prior to working on the project with re -certification completed as required by [CONTACT_941] N IH or IRB.  This 
will be monitored and implemeneted by [CONTACT_1758] c oordinator.   
 Telephone screeners will be required to complete two practice inteviews with the first actual study interview 
supervised and evaluated by [CONTACT_079], Study Coordinator, or trained and ce rtified telephone 
screener.  The Study coordinator or other site personnel appointed to do will audit the first telephone screening interview completed and will co ntinue to do so until the questionnaire and final outcome are completed without 
error.  
 
 [ADDRESS_286055] practice visit will be supervised by [CONTACT_1268], Clinical Coordinator, or a trained and certified tester  (more practice may be deemed nec-
essary by [CONTACT_63634]) .  The first actual study assessment visit will also be supervised and evaluated by [CONTACT_236330].  To further achieve internal va lidity  and inter -rater reliability , the test ers will observe  and 
evaluate each other at least once per replicate and audit each o ther’s testing records.   Participant data forms 
should be audited by a different tester within [ADDRESS_286056] once per replicate and a u-
dit each other’s intervention records.  The first actual intervention visit conducted by [CONTACT_236331] s u-
pervised and evaluated by [CONTACT_236332] a certified trainer .  Participant training data forms will be 
audited by a differe nt trainer  within [ADDRESS_286057] testing/intervention folder 
completed  and rescored by [CONTACT_236333]/trainer, and will continue to do so until the procedure is completed wit h-
out error.  Random quality control audits will be performed on 2 0% of the partic ipant folders each replicate .   
 Study documents and pertinent records will be available for inspection by [CONTACT_236334] (e.g., NIH or IRB) as requested.   
 
11.[ADDRESS_286058] Officer.  In the unlikely case of study- related serious a dverse events, an interim analysis will be 
performed in order to determine whether a change in the risk/benefit ratio has occurred and reviewed by [CONTACT_236335]. Ji.   If so, this change will be brought to the attention of the USF IRB for revie w, current and f u-
ture participants will be notified of this change, and stoppi[INVESTIGATOR_236258].  
 
11.[ADDRESS_286059] study visit, 
participants will be directly interviewed about any possible adverse events that occurred since their initial visit.  A study physician and/or [CONTACT_236346]  will follow -up with the participant for any adverse events.  The partic i-
pant will be referred to prope r treatment.  
 
11.3 Safety Monitoring  
The PI  [INVESTIGATOR_236259]’ s afety.  
 [CONTACT_236345] will perform analyses to  monitor participant safety, evaluate the progress of the study, to review proc e-
dures for maintaining t he confidentiality of data, the quality of data collection, management, and analyses.  
 All OHRP and local IRB requirements for r eporting adverse events will be followed.   
 
11.[ADDRESS_286060] confidentiality.  All records will be kept in a locked file cabinet.   All 
computer entry of data forms will be done using participant ids only and without partic ipant names .  Clinical 
information will not be released without written permission of the participant , except as necessary for monitor-
ing by [CONTACT_1744], NIH , or the OHRP   
11.5 Study Modification/Discontinuation  
 The study may be modified or discontinued a t any time by [CONTACT_941] I RB, the NIH , the OHRP, or other government 
agencies as part of their duties to ensure that r esearch subjects are protected.  
 Study Modifications  
Date  Imple-
mented  Modification  Rationale  
04/23/2018  For the pi[INVESTIGATOR_236260], the FAS, 
Animals/ Boys’ Names, and Fruits/ Furniture version will be 
administered at baseline and The music listening condition 
involves a lesson on musical intstruments. Thus, we decided 
that using this version  of verbal 
 [ADDRESS_286061] i-
cate. We changed the order for 
furture replicates such that Veg-etables/Musical Instruments version is administered at bas e-
line and the Fruits/Fur niture ver-
sion will be administered at 
post-test. 
07/16 /[ADDRESS_286062] received music 
training. 
07/16/ 2018  Page 15,  5.7 Interventions A d-
ministration and D uration.  We 
omitted the sentence that indi-cated a textbook will be provi d-
ed and weekly homework will be assigned.  The study inve stigators met to 
discuss the study progress and any modifications needed since completion of the pi[INVESTIGATOR_236261]. 
The trainers and a Co- I noted 
that it was difficult to make the homework assignments and en-gagment equiv alent across the 
two conditions. It was decided that we will omit the homework 
for replicate 1 and the remai n-
der of the study.  Participants 
will only access the textbooks during the in -lab training ses-
sions. There is no evidence that 
homework is r equired for pi[INVESTIGATOR_236262].  E n-
suring equi valency of the two 
conditions is the rationale.  
07/16 /2018  Page 12, 5.2 Exclusion criteria. 
We added, “which interferes The PI [INVESTIGATOR_236263] 
 [ADDRESS_286063]” to 
exclusion criteria regarding 
numbness or tingling.  numbness or tingling in any fi n-
ger was too conservative and 
that individuals were being ex-
cluded that would be able to successfully participate in the study.  We deci ded to add this 
phrase in an attempt to only ex-clude those who would not be able to successfully complete 
the interve ntion.  
07/16/2018  Pages 13 -14, 5.3 Enrollment 
Procedures.  Those who score a 26 or better on the MoCA will be enrolled in the study (not 27). 
Those potentially eligible who score between 20 to 25 (not 26) on the MoCA who were not r e-
ferred by [CONTACT_236336]-sician will also complete a clin i-
cal evalu ation visit.   The PI [INVESTIGATOR_236264] u-
ation were too stringent . The 
study investigators deci ded to 
use the traditional cut -point of 
26 for MoCA to deter mine who 
is eligible and who requires fur-ther evaluation.   
07/30/2018  Page 14, 5.3 Enrollment Proc e-
dures.  We clarify that c linically 
significant abnormalities are shared with the participants who are encouraged to seek treat-ment.  We added the phrase, 
“that would likely interfere with their ability to benefit from inter-vention”  regarding any signif i-
cant clinical abnorma lities.  This has been our procedure 
beginning in replicate 1.  The 
goal is to be inclusive and to al-low tho se who could potentially 
benefit from intervention to con-tinue partic ipation in the study.  
 
 44 Keys to Staying Sharp 
  Version 2 
 
 
Page 44 of 58  
 12 REFERENCES  
 
1. Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M Reenvisioning Clinical Science: Unifying 
the discipline to improve the public health  Clinical Psychological Science 2014;2(1):22- 34  doi: 
10.1177/216770261349793225821658 2. Gates GA, Gibbons LE, McCurry SM, Crane PK, Feeney PK, Larson EB Executive dysfunction and 
presby[CONTACT_236337] 2010;23:218- 23  doi: 10.1097/WNN.0b013e3181d748d7 
3. Gates GA, Anderson ML, Feeney MP, McCurry SM, Larson EB Central auditory dysfunction in older 
persons with memory impairment or Alzheimer dementia  Archives of  Otolaryngology -- Head and Neck 
Surgery 2008;134(7):771 -[ZIP_CODE]/07/23  doi: 10.1001/archotol.134.7.77118645130 
4. Gold M, Lightfoot LA, Chisolm T Hearing loss in a memory disorders clinic:  A specially vulnerable 
population Archives of Neurology 1996;53:922- 8  
5. Albers MW, Gilmore GC, Kaye JA, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, 
Cruickshanks K, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm TH, Holtzer R, Hyman B, Lin F, McKee JQ, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang L I At the interface of sensory and motor 
dysfunctions and Alzheimer's disease  Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2015;11:70- 98  doi: 10.1016/j.jalz.2014.04.514 
6. Gates GA, Beiser A, Rees T, D'Agostino R, Wolf P Central audi tory dysfunction may precede the onset 
of clinical dementia in people with probable Alzheimer's disease  Journal of the American Geriatrics Society 2002;50:482- 8  doi: 10.1046/j.1532- 5415.2002.[ZIP_CODE].x 
7. Gates GA, Cobb J, Linn R, Rees T, Wolf P, D'Agostino R Central auditory dysfunction, cognitive 
dysfunction, and dementia in older people  Archives of Otolaryngology --  Head and Neck Surgery 
1996;122:161- 7  doi: 10.1001/archotol.1996.01890140047010 
8. Schneider BA, Pi[INVESTIGATOR_120307] -Fuller MK. Implications of perceptual deterioration for cognitive aging research. 
In: Craik FIM, Salthouse TA, editors. The Handbook of Aging and Cognition. Mahwah, NJ: Lawrence Erlbaum 
Associates, Inc; 2000. p. 155- 220. 
9. Nikjeh D, Lister J, Frisch S Hearing of note:  An electrophysiologi c and psychoacoustic comparison of 
pi[INVESTIGATOR_236265] 2008;45:994- 1007  
10. Nikjeh D, Lister J, Frisch S Pre -attentive cortical evoked responses to pure tones, music, and speech: 
Influence of mus ic training  Ear and Hearing 2009;30:432- [ADDRESS_286064] Age -Related Declines in Categorical Vowel Perception  Journal of Neuroscience 
2015;35(3):1240- 9  
12. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg B Mild cognitive impairment 
represents early -stage Alzheimer's disease  Archives of Neurology 2001;58:397- 405  doi: 
10.1001/archneur.58.3.397. 13. Corner L, Bond J Bei ng at risk of dementia: Fears and anxieties of older adults  Journal of Aging studies 
2004;18:143- 55  doi: 10.1016/j.jaging.2004.01.007 
14. Seshadri S, Wolf PA Lifetime risk of stroke and dementia: Current concepts, and estimates from the 
Framingham Study  Lancet Neurology 2007;6(12):1106- 14  doi: 10.1016/S1474- 4422(07)[ZIP_CODE]- 018031707 
15. Sands LP, Yaffe K, Lui LY, Stewart A, Eng C, Covinsky K The effects of acute illness on ADL decline 
over 1 year in frail older adults with and without cognitive impairment   Journals of Gerontology Series A, 
Biological Sciences and Medical Sciences 2002;57:M449- M54  
 [ADDRESS_286065] costs of illness and NIH support: Fiscal 
year 2000 update: National Institute of Health; 2000. Available from: 
http://ospp.od.nih.gov/ecostudies/COIreportweb.htm . 
17. Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM Monetary costs of dementia in the [LOCATION_002]  New England Journal of Medicine 2013;368(14):1326-34  doi: 10.1056/NEJMsa120462923550670 18. Hobbs FB. Population of the [LOCATION_002] 2008. Available from: http://www.census.gov/population/www/pop-profile/elderpop.html
. 
19. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M Global prevalence of dementia: A Delphi consensus study  Lancet 2005;366:2112-7  doi: 10.1016/S0140-6736(05)[ZIP_CODE]-0 20. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM Forecasting the global burden of Alzheimer's disease  Alzheimer's & Dementia 2007;3:181 -91  doi: 10.1016/j.jalz.2007.04.381 
21. DeCarli C M ild cognitive impairment: Prevalence, prognosis, aetiology, and treatment  The Lancet 
Neurology 2003;2:15-21  doi: 10.1016/S1474-4422(03)[ZIP_CODE]-X 22. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos E, Kokmen E Mild cognitive impairment: Clinical characterization and outcome  Archives of Neurology 1999;56:303-8  doi: 10.1001/archneur.56.3.303 23. Petersen RC Mild cognitive impairment as a diagnostic entity  Journal of Internal Medicine 
2004;256(3):183-94  doi: 10.1111/j.1365-2796.2004.[ZIP_CODE].x 24. Reuter -Lorenz PA, Park DC How does it STAC up? Revisiting the scaffolding theory of aging and 
cognition  Neuropsychology Review 2014;24(3):355-70  doi: 10.1007/s11065-014-9270-925143069 25. Belleville S Cognitive training for persons with mild cognitive impairment  International 
Psychogeriatrics 2008;20(1):57-66  doi: 10.1017/S104161020700631X 26. Stott J, Spector A A review of the effectiveness of memory interventions in mild cognitive impairment (MCI)  International Psychogeriatrics 2010;23:526-38  doi: 10.1017/S1041610210001973  27. American Speech Language Hearing Association. Guidelines for manual pure-tone threshold audiometry [guidelines]. 2005. 28. Gates GA, Gibbons LE, McCurry SM, Crane PK, Feeney MP, Larson EB Executive dysfunction and presby[CONTACT_236337] 2010;23(4):218-23  doi: 10.1097/WNN.0b013e3181d748d721150347 29. Li KZH, Lindenberger U Relations between aging sensory/sensorimotor and cognitive functions  Neuroscien ce and Biobehavioral Reviews 2002;26(7):777-83  doi: 10.1016/S0149-7634(02)[ZIP_CODE]-8 
30. Fabrigoule C, Rouch I, Taberly A, Letenneur L, Commenges D, Mazaux J, Orgogozo J, Dartigues JF Cognitive process in preclinical phase of dementia  Brain 1998;121(1):135-41  31. Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease  Journal of the International Neuropsychological Society 2008;14(2):266-78  doi: 10.1017/S135561770808030218282324 32. Belleville S, Chertkow H, Gauthier SUS  Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairmentUSUS   NeuropsychologyUS  2007;21(4):458-69US Epub US   doi: 10.1037/0894-4105.21.4.458US PubMed PMID: US 33. Stopford CL, Thompson JC, Neary D, Richardson AM, Snowden JS Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia  Cortex 2010;48(4)2011/01/18  doi: 10.1016/j.cortex.2010.12.002 21237452 34. Gates GA, Beiser A, Rees TS, D'Agostino RB, Wolf PA Central auditory dysfunction may precede the onset of clinical dementia in people with probable Alzheimer's disease  Journal of the American Geriatrics Society 2002;50(3):482-8 11943044 
 46 Keys to Staying Sharp 
  Version 2 
 
 
Page 46 of 58  
 35. Gates GA, Anderson ML, McCurry SM, Feeney MP, Larson EB Central auditory dysfunction as a 
harbinger of Alzheimer dementia  Arch Otolaryngol Head Neck Surg 2011;137(4):390- 5  doi: 
10.1001/archoto.2011.[PHONE_4937] 
36. Humes LE, Dubno JR, Gordon- Salant S,  Lister JJ, Cacace AT, Cruickshanks KJ, Gates GA, Wilson RH, 
Wingfield A Central presby[CONTACT_236338]: A review and evaluation of the evidence  Journal of the American Academy of Audiology 2012;23(8):635- 66  doi: 10.3766/jaaa.23.8.[ADDRESS_286066] M , Kampfe Nordstrom C, Jelic V, Rosenhall U Central 
auditory function in early Alzheimer's disease and in mild cognitive impairment  Age and Ageing 2011;40(2):249- 54  doi: 10.1093/ageing/afq16821233090 
39. Association AS -L-H. Guidelines for manual pure -tone threshold audiometry [guidelines]. 2005.  
40. American Speech -Language -Hearing Association. Central auditory processing: Current status of status 
of research and implications for clinical practice. 1996. 41. Pi[INVESTIGATOR_120307] -Fuller MK, Singh G Effects of age on aud itory and cognitive processing: Implications for 
hearing aid fitting and audiologic rehabilitation  Trends in Amplification 2006;10:29- 59  doi: 
10.1177/108471380601000103  42. Anderson S, White -Schwoch T, Parbery- Clark A, Kraus N Reversal of age- related neural timing delays 
with training  Proceedings of the National Academy of Sciences of the [LOCATION_002] of America 2013;110(11):4357- 62  doi: 10.1073/pnas.121355511023401541 
43. Pi[INVESTIGATOR_120307] -Fuller MK, Schneider BA, Daneman M How young and old adults listen to a nd remember 
speech in noise  Journal of the Acoustical Society of America 1995;97:593- 608  
44. Rabbitt PM Channel -capacity, intelligibility and immediate memory  Quarterly Journal of Experimental 
Psychology 1968;20(3):241- 8  doi: 10.1080/146407468084001585683763 
45. Tun PA, McCoy S, Wingfield A Aging, hearing acuity, and the attentional costs of effortful listening  
Psychology and Aging 2009;24(3):761- 6  
46. Grimes AM, Grady CL, Foster NL, Sunderland T, Patronas NJ Central auditory function in Alzheimer's 
disease  Neurology 1985;35(3):352- 8 3871922  
47. Jäncke L, Shah NJ Does dichotic listening probe temporal lobe functions?  Neurology 2002;58(5):736-
43  48. Duchek JM, Balota DA Failure to control prepotent pathways in early stage dementia of the Alzheimer's 
type: Evidence from dichotic listening  Neuropsychology 2005;19(5):687- 95  doi: 10.1037/0894-
4105.19.5.[ADDRESS_286067] T, Zatorre RJ, Growdon JH Auditory function in Alzheimer's disease  
Neurology 1993;43(10):1893- 9 8413944 
50. Sinha [LOCATION_006], Hollen KM, Rodriguez R, Miller CA Auditory system degeneration in Alzheimer's disease  
Neurology 1993;43(4):779- 85 8469340 
51. De Santia S, de Leona MJ, Rusinekb H, Convita A, Tarshisha CY, [COMPANY_002]a A, Tsuic WH, Kandila E, 
Boppanna M, Daisleya K, W angd GJ, Schlyere D, Folere J, al. e Hippocampal formation glucose metabolism 
and volume losses in MCI and AD  Neurobiology of Aging 2001;22(4): 529–39  doi: 10.1016/S0197-
4580(01)[ZIP_CODE]- 5 
52. Wingfield A, Peelle J The effects of hearing loss on neural processing and plasticity  Frontiers in 
Systems Neuroscience 2015;9:1- 4  
53. Rauschecker JP, Scott SK Maps and streams in the auditory cortex: nonhuman primates illuminate 
human speech processing  Nature Neuroscience 2009;12:718- 24  doi: 10.1038/nn.2331 
 47 Keys to Staying Sharp 
  Version 2 
 
 
Page 47 of 58  
 54. Davis MH, Johnsrude I Hierarchical processing in spoken language comprehension  The Journal of 
Neuroscience 2003;23(8):3423- 31  
55. Eckert MA, Cute SL, Vaden KI, Jr., Kuchinsky SE, Dubno JR Auditory cortex signs of age -related 
hearing loss  Journal of the As sociation for Research in Otolaryngology 2012;13(5):703- 13  doi: 
10.1007/s10162- 012-0332- [ADDRESS_286068] learning in adults  Human Brain Mappi[INVESTIGATOR_007] 2007;28(10):995- 1006  doi: 10.1002/hbm.2033017133399 
57. Gates GA, Cobb JL, Linn RT, Rees T, Wolf PA, D'Agostino RB Central auditory dysfunction, cognitive 
dysfunction, and dementia in older people  Archives of Otolaryngology --  Head and Neck Surgery 
1996;122( 2):161- 7 8630210 
58. Anderson S, Kraus N Auditory training: Evidence for neural plasticity in older adults  Perspectives in 
Hearing and Hearing Disorders: Research and Diagnostics 2013;17:37- 57  doi: 10.1044/hhd17.[PHONE_4938] 
59. Zendel BR, Alain C Musici ans experience less age- related decline in central auditory processing  
Psychology and Aging 2012;27(2):410- 7  doi: 10.1037/a002481621910546 
60. Mishra SK, Panda MR, Herbert C Enhanced auditory temporal gap detection in listeners with musical 
training  Journal of the Acoustical Society of America 2014;136(2):EL173 -EL8  
61. Kraus N, Chandrasekaran B Music training for the development of auditory skills  Nature Reviews 
Neuroscience 2010;11:599- 605  doi: 10.1038/nrn2882 
62. Humes LE, Busey TA, Craig J, Kewley -Port D Are age- related changes in cognitive function driven by 
[CONTACT_654]-related changes in sensory processing?  Attention, Perception, & Psychophysics 2013;75(3):508- 24  doi: 
10.3758/s13414- 012-0406- [ADDRESS_286069] icity and functional losses in the aged:  Scientific 
bases for a novel intervention  Progress in Brain Research 2006;157:81- 109  
64. Edwards JD, Clark D, Xu H, Unverzagt FW Computerized process -based training reduces dementia 
prevalence over ten years  (in  preparation)  
65. Park DC, Lodi -Smith J, Drew L, Haber S, Hebrank A, Bischof GN, Aamodt W The impact of sustained 
engagement on cognitive function in older adults: The Synapse Project  Psychological Science 2014;25(1):103-
12  doi: Doi 10.1177/0956797613499592WOS:000329486300011 66. Verghese J, Lipton RB, Katz MJ, Hall CB, Derby [CONTACT_28474], Kulansky G, Ambrose A, Sliwinski M, Buschke 
H Leisure activities and risk of dementia in the elderly  New England Journal of Medicine 2003;348:2508- 16  
doi: 10.1056/NEJMoa022252 67. Seinfeld S, Figueroa H, Ortiz -Gil J, Sanchez -Vives MV Effects of music learning and pi[INVESTIGATOR_236266], mood, and quality of life in older adults  Frontiers in Psychology 2013;4  doi: 
10.3389/psyg.2013.[ZIP_CODE] 
68. Paquette S, Goulet GM  Lifetime benefits of musical training  Frontiers in Neuroscience 2014;8:1 -2  doi: 
10.3389/fnins.2014.[ZIP_CODE] 
69. Alain C, Zendel BR, Hutka S, Bidelman GM Turning down the noise: The benefit of musical training on 
the aging auditory brain  Hearing Research 2014;308:162- 73  doi: 10.1016/j.heares.2013.06.00823831039 
70. Oechslin MS, Descloux C, Croquelois A, Chanal J, Van De Ville D, Lazeyras F, James CE 
Hippocampal volume predicts fluid intelligence in musically trained people  Hippocampus 2013;23(7):552- 8  
doi: 10.1002/hipo.[ADDRESS_286070] 2010;16:566- 77  doi: 10.1177/1073858410377805 
72. Bidelman GM, Weiss MW, Moreno S, Alain C Coordinated plasticity in brainstem and auditory cortex 
contributes to enhanced categorical speech perception in musicians  European Journal of Neuroscience 2014;40(4):2662- 73  doi: 10.1111/ejn.1262724890664 
 48 Keys to Staying Sharp 
  Version 2 
 
 
Page 48 of 58  
 73. James CE, Michel CM, Britz J, Vuilleumier P, Hauert CA Rhythm evokes action: Early processing of 
metric deviances in expressive music by [CONTACT_236339][INVESTIGATOR_007] 2012;33(12):2751-67  doi: 10.1002/hbm.2139721932257 74. Strait DL, Chan K, Ashley R, Kraus N Specialization among the specialized: Auditory brainstem function is tuned in to timbre  Cortex 2012;48(3):360-2  doi: 10.1016/j.cortex.2011.03.01521536264 75. O'Brien JL, Nikjeh D, Lister J Interaction of musicianship and aging: A comparison of cortical auditory evoked potentials  Behavioural Neurology 2015;2015:1-12  doi: dx.doi.org/10.1155/2015/545917 76. Parbery -Clark A, Strait DL, Hittner E, Kraus N Musical training enhances neural processing of binaural 
sounds  The Journal of Neuroscience 2013;33(42):[ZIP_CODE]-7  doi: 10.1523/JNEUROSCI.5700-12.[ADDRESS_286071] Differential effects of age on sequence learning and sensorimotor adaptation  Brain Research Bulletin 2006;70(4-6):337-46  doi: 10.1016/j.brainresbull.2006.06.[ADDRESS_286072] JA, Burutolu TB, Fling BW, Gordon MT, Gwin JT, Kwak Y, Lipps DB Motor control and aging: links to age- related brain structural, functional, and biochemical effects  Neuroscience and 
Biobehavioral Reviews 2010;34(5):721-33  doi: 10.1016/j.neubiorev.2009.10.00519850077 79. Han Y, Yang H, Lv YT, Zhu CZ, He Y, Tang HH, Gong QY, Luo YJ, Zang YF, Dong Q Gray matter density and white matter integrity in pi[INVESTIGATOR_236267]' brain: A combined structural and diffusion tensor MRI study  Neuroscience Letters 2009;459(1):3-6  doi: 10.1016/j.neulet.2008.07.05618672026 80. Bangert M, Schlaug G Specialization within the specialized in features of external human brain 
morphology  European Journal of Neuroscience 2006;24:1832-4  81. Bugos JA The benefits of music instruction on processing speed, verbal fluency, and cognitive control in aging  Music Education Research International 2010;4(1- 9)  
82. Bugos JA, Perlstein WM, McCrae CS, Brophy TS, Bedenbaugh PH Individualized pi[INVESTIGATOR_236268] 2007;11(4):464-71  doi: 10.1080/[ADDRESS_286073] Relationships between regional cerebellar volume and sensorimotor and cognitive function in young and older adults  Cerebellum 2013;12(5):1-30  doi: 10.1007/s12311-013-0481-z 84. Miendlarzewska EA, Trost WJ How musical training affects cognitive development: Rhythm, reward, and other modulating variables.  Frontiers in Neuroscience 2014;7(1-18)  doi: 10.3389/fnins.2013.[ZIP_CODE] 85. Seppanen M, Pesonen AK, Tervaniemi M Music training enhances the rapid plasticity of P3a/P3b event-related brain potentials for unattended and attended target sounds  Attention, Perception, and Psychophysiology 2012;74(3):600-12  doi: 10.3758/s13414-011-0257-[ADDRESS_286074] musical activity predicts cognitive aging variability: Direct comparison with general lifestyle activities  Frontiers in Human Neuroscience 2012;6:1 -11  
87. Hanna-Pladdy B, MacKay A The relation between instrumental musical activity and cognitive aging  Neuropsychology 2011;25(3):378-86  doi: http://dx.doi.org/10.1037/a0021895
  
88. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment  Journal of the American Geriatrics Society 2005;53:695–[ADDRESS_286075]: Good-Lite; 2010 [October 21, 2010]. A vailable from: 
www.good- lite.com
. 
90. Conradsson M, Rosendahl E, Littbrand H, Gustafson Y, Olofsson B, Lovheim H Usefulness of the Geriatric Depression Scale 15 -item version among very old people with and without c ognitive impairment  
Aging & Mental Health 2013;17(5):638-45  doi: 10.1080/13607863.2012.[ADDRESS_286076], community -dwelling elderly primary care patients  Journal of the 
American Geriatrics Society 2005;53(9):1570-6  doi: 10.1111/j.1532-5415.2005.[ZIP_CODE].x16137289 
 49 Keys to Staying Sharp 
  Version 2 
 
 
Page 49 of 58  
 92. Bugos JA, Groner A The effects of instrumental training on non- verbal reasoning in eighth- grade 
students  Research Perspectives in Music Education 2009;14:14- [ADDRESS_286077] discs in auditory evaluation  Journal of 
Rehabilitation Research and Development 1993;30(3):342- [ADDRESS_286078] No.6  Journal of the American 
Academy of Audiology 1994;5:269- 77  
95. Konkle DF, Beasley DS, Bess FH Intelligi bility of time -altered speech in relation to chronological aging  
Journal of Speech, Language, and Hearing Research 1977;20(1):108- 15  doi: 10.1044/jshr.2001.108 
96. Beasley DS, Bratt GW, Rintelmann WF Intelligibility of time -compressed sentential stimuli  Journal of 
Speech, Language, and Hearing Research 1980;23:722- 31  doi: 10.1044/jshr.2304.[ADDRESS_286079]- recognition 
performance  Journal of the American Academy of Audiology 2003;14: 453-[ADDRESS_286080] ed. London: Charles Griffin & Co. Ltd; 1964. 
99. Wilson RH, Morgan DE, Dirks DD A proposed SRT procedure and its statistical precedent  Journal of 
Speech and Hearing Disorders 1973;38:184- [ADDRESS_286081] reliability of the Words -in-Noise (WIN) Test  
Journal of the American Academy of Audiology 2007;18(10):813- 25  
101. Wilson RH, McArdle RA, Smith SL An evaluation of the BKB -SIN, HINT, QuickSIN, and WIN 
materials on listeners with normal hearing and listeners with hearing loss.  Journal of Speech, Language, and Hearing Research 2007;4:[ADDRESS_286082] for assessing central aud itory 
function in Alzheimer's disease  Audiology 1995;34(2):85- 90  
103. Speaks C, Jerger J, Jerger S Performance -intensity characteristics of synthetic sentences. Journal of 
Speech, Language, and Hearing Research  Journal of Speech, Language, and Hearing R esearch 1966;9(2):305-
12  doi: 10.1044/jshr.0902.305 104. Gates GA, Anderson ML, McCurry SM, Feeney MP, Larson EB Central auditory dysfunction as a 
harbinger of Alzheimer dementia  Archives of Otolaryngology -  Head and Neck Surgery 2011;137(4):390- 5  
doi: 10.1001/archoto.2011.[ADDRESS_286083] of temporal resolution  American 
Journal of Audiology 2006;15:133- 40  doi: 10.1044/1059- 0889(2006/017)  
106. Lister J, Roberts RA, Krause JC, DeBiase D, Carls on H An adaptive clinical test of temporal resolution: 
Within -channel and across -channel gap detection  International Journal of Audiology 2011;50:375- 84  doi: 
10.3109/14992027.2010.[ADDRESS_286084] of temporal resolution: Age effects  
International Journal of Audiology 2011;50(6):367- 74  doi: 10.3109/14992027.2010.551218 
108. Cox R A structured approach to hearing aid selection  Ear and Hearing 1985;6(5):226- 39  
109. Delis DC, Kaplan E, Kramer JH. Delis -Kaplan Executive Function System (D -KEFS). San Antonio, 
TX: The Psychological Corporation; 2001. 110. Ruff RM, Light RH, Parker SB Benton Controlled Oral Word Association Test: Reliability and updated 
norms  Archives of Clinical Neuropsychology 1996;11:329- 38  
111. Duff Canning SJ, Leach DL, D. S, Ngo L, Black SE Diagnostic utility of abbreviated fluency measured 
in Alzheimer disease and vascular dementia  Neurology 2004;62:556- 62  doi: 10.1212/WNL.62.4.556 
112. Strauss ME, Sherman EM, Spreen O. A compendium of neuropsychological tests: Administration, 
norms, and commentary. 3rd ed: Oxford University Press; 2006. 
 [ADDRESS_286085] Battery. Tucson, AZ: 
Neuropsychological Press; 1985. 
114. Lezak MD. Neuropsychological Assessment. 3rd ed. [LOCATION_001]: Oxford University Press; 1995. 115. Owsley C, Sloane ME, McGwin G, Ball KK Timed instrumental activities of daily living tasks: 
Relationship to cognitive function and everyday performance assessments in older adults  Gerontology 2002;48(4):254-65  doi: 10.1159/[ADDRESS_286086] of everyday attention (TEA)  Test 
Reviews 2001;4(1):51-[ADDRESS_286087] of Everyday Attention Manual: Pearson Assessment; 1994. 32 p. 118. Gordon EE. Advanced Measures of Music Audiation. Chicago, IL: GIA Publications; 1989. 119. Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Robers RW The self- efficacy scale:  
Construction and validation  Psychological Reports 1982;51:663-71  120. Zelenak M Development and validation of the Music Performance Self -Efficacy Scale  Music Education 
Research International 2010;4:31-43  121. Bugos JA, Kochar S, Maxfield N Intense pi[INVESTIGATOR_236269]-efficacy and physiological stress in 
aging  Psychology of Music 2016:1-14  doi: 10.1177/0305735615577250 122. Rabipour S, Davidson PS Do you believe in brain training? A questionnaire about expectations of computerized cognitive training  Behavioural Brain Research 2015  doi: 10.1016/j.bbr.2015.01.00225591472 123. Faul F, Erdfelder E, Lang AG, Buchner A G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences  Behavior Research Methods 2007;39(2):175-912007/08/19  doi: 10.3758/BF0319314617695343 124. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988. 125. Holm S A simple sequentially rejective multiple test procedure  Scandinavian Journal of Statistics 
1979;6:65-70  126. Roderick JA, Rubin DB, editors. Statistical Analysis with Missing Data. 2nd ed2002. 127. Hayes AF. PROCESS: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling [White paper]. 2012. 128. Selig JP, Preacher KJ Mediation models for longitudinal data in developmental research  Reseach in Human Development 2009;6(2-3):144-[ADDRESS_286088]  Psychological Science 
2007;18:223-39  doi: 10.1111/j.1467-9280.2007.[ZIP_CODE].x 130. Chermak GD, Musiek FE. Central auditory processing disorders: New perspectives. San Diego, CA: Singular1997.  13. Data availab ility: The data from this study are publicly available. Please contact P I Edwards at 
jed-
wards [EMAIL_4585] to request the data.    
 14. R esults  
 
Recruitment and enrollment began in January [ADDRESS_286089]. Nine-
 51 Keys to Staying Sharp 
  Version 2 
 
 
Page 51 of 58  
 teen participants were excluded from analyses due to  a head injury ( n=1), undergoing anesthesia ( n=10), or 
hospi[INVESTIGATOR_059] ( n=8) before post -test. Please see Figure 1 for details.  
The randomized gr oups did not differ in sex, χ2(1)=.787, p=.375, ethnicity χ2(1)=.167, p=.683, or race, 
χ2(1)=.045, p=.832. The Music Reading Assessment scores did not differ between the two groups, t(266)= -.958, 
p=.338. The randomized groups did not signi ficantly differ i n age, F (1,266)=.293, p=.589, education, 
F(1,266)=.369, p =.544, MoCA, F(1,266)=.427, p =.514, or GDS, F (1,266)=.943, p=.332. However, there were 
marginally significant group differences for PTA in the left ear, F (1,266)=3.31, p=.070 and sta tistically signif i-
cant group differences for both PTA in the right ear, F (1,266)=6.69, p=.010, and visual acuity, F (1,266)=8.99, 
p=.003. The music listening group tended to have worse hearing, while the pi[INVESTIGATOR_236270]. See Table 1. The groups also differed significantly in their expectations regarding potential 
benefits of their r andomized group, F (1,214)=15.07, p<.001. The pi[INVESTIGATOR_236271] 
5.55 while the music listening group had an aver age rating of 4.99, indicating the pi[INVESTIGATOR_236272]. The pi[CONTACT_1629] o training group also rat-
ed their condition as more challenging with 92% agreeing that the intervention w as challenging as  compared to 
86.3% of the music listening group indicating their condition was challenging ( p<.001) . 
Principal component analysis with varimax rotation was conducted to reduce the number of variables for 
analyses. Please see Supplemental T able A  for detail s. The first factor reflected cognitive performance speed 
and included the Trail Making Test, Digit Coding, and the TEA visual elevator and phone search subtests. The second factor included all three verbal fluency subtests. The third fact or reflected CAP and included DDT, DSI, 
TCS, and WIN. The fourth factor included two indices from the TEA phone search while counting and visual elevat or accuracy. The fifth composite included ATTR across - and within-  channel performance. Baseline com-
posit es of cognitive performance, verbal fluency, ATTR, CAP, and everyday function were created by [CONTACT_236340]-
ing z scores after the reverse- scaling of items with negative factor loadings. Post -test scores were standardized 
 [ADDRESS_286090] as indicated by a significant group- by-time interac-
tion. Covariates included hearing PTA, visual acuity, and expectations. The group- by-time interactions were not 
statis tically significant for any of the outcomes ( ps>.194). See Table 2. The results did not change when we in-
cluded only those  who were adherent ( ps>.180). See Supplementary Table B. Pi[INVESTIGATOR_236273]-
ly enhance CAP, cognition, or everyday function as compared to music listening. We further examined if inter-
vention effects varied by [CONTACT_236294]  (Supplementary Table  B). There were no significant group- by-time-by-
MCI status interactions indicating those with and without MCI did not show differential benefit ( ps>.245). 
Thus, MCI did not significantly moderate the effects of pi[INVESTIGATOR_236185].  
Effect sizes for pi[INVESTIGATOR_236274] [ADDRESS_286091] of the TEA ( ds>=0.25). Raincloud plots of individual assessment and composite variables are included in the sup-
plement al materials.  
Results indicated significant effects of time for ATTR in all models and significant effects of time for 
CAP in the primary and adherent analyses indicating improved performance from pre - to post - training. Signifi-
cant effects of time were f ound for cognition and TEA in the primary and adherent analyses, indicating a ten-
dency for decline across time. With respect to covariate effects, CAP, ATTR, and cognitive performance were significantly impacted by [CONTACT_13540]. Similarly, Time d IADL and cognit ive performance varied significantly by 
[CONTACT_178744]. Those with poorer hearing or vision tended to perfo rm worse on these outcomes. Interestingly, 
 [ADDRESS_286092] abilities  was 
associated with poorer performance. See Table 2. Additional sensitivity analyses examined if there were differ-
ential effects by [CONTACT_4321]. No significa nt group- time-sex interactions were evident ( ps>.119) , and the pattern of re-
sults was the same when analyses were stratified by [CONTACT_4321].   
 [ADDRESS_286093] ening  
Cogni tive status  Non-MCI  
M (SD) MCI  
M (SD) Non-MCI  
M (SD) MCI  
M (SD) 
 
n (%) n (%) n (%) n (%) 
Age in years  69.1 (5.5)  71.4 (7.1) 69.6 (5.2)  72.1 (5.7)  
Education in years  16.0 (2. 3) 16.5 (2.2) 16.0 (2. 1) 15.4 (2. 3) 
Sex (% female)  63 (65%)  18 (48% ) 58 (59%)  17 (44%)  
Music Reading Assessment 
score (/ 40) 2.52 (4.31) 2.43 (3.83) 3.42 (5.41)  2.08 (4.29)  
Montreal Cognitive Assessment 
score (/30)  26.6 (2.1)  23.3 (1.4)  26.6 (1.9)  22.8 (1.6)  
Geriatric Depression Scale  
short -form  score (/ 15) 0.9 (1.2)  1.1 (1.1)  0.9 (1.1)  0.6 (0.9)  
Pure tone average  left ear (dB)+ 19.8 (9.4)  20.4 (9. 4) 20.9 (10.8)  27.7 (15.9)  
Pure tone average r ight ear 
(dB)+*  18.6 (10. 3) 20.4 (9.9) 22.4 (14.0)  25.8 (11.6)  
Visual acuity (logMAR)+*  .04 (.12)  .09 (.15)  .01 (.13)  .01 (.10 ) 
Expectati ons (rating/7)*  5.4 (1.2)  5.8 (0.8)  4.9 (0.8  5.3 (0.8)  
Note.  MCI=mild cognitive impairment. +Lower scores reflect better performance. *Significant differences 
by [CONTACT_236341], visual acuity, and expectation s (ps<.01). 
 [ADDRESS_286094]- training across  composite outcomes of central auditory processing, cognition, 
and everyday function.  
 Estimate  SE p 
 Estimate  SE p 
 ATTR+    Central auditory processing  
Intercept  53.90  1.17 <.001    46.25  0.73 <.001  
Group  -2.24 2.37 .346   -1.72 1.49 .249 
Time  -2.77 0.68 <.001    2.29 0.36 <.001  
Group x time  1.51 1.35 .265   .465 0.71 .515 
Hearing  0.12 0.06 .030   -0.63 0.04 <.001 
Visual acuity  6.24 4.71 .187   -7.270  3.97 0.07 
Expectations  0.79 0.59 .185   -1.20 0.49 .016 
  Verbal fluency    Cognition  
Intercept  49.32  0.98 <.001    51.81  0.90 <.001  
Group  -1.81 2.00 .367   -2.62 1.84 .157 
Time  0.41 0.48 .393   -1.40 0.42 .001 
Group x time  -0.29 0.96 .763   0.39 0.84 .638 
Hearing  -0.09 0.06 .134   -0.14 0.06 .016 
Visual acuity  -6.55 5.33 .220   -15.45  5.12 .003 
Expectations  -0.79 0.67 .234   -1.96 0.64 .003 
 Timed IADL+    Test of Everyday Attention  
Intercept  48.89  1.32 <.001 
 62.34  1.15 <.001  
 56 Keys to Staying Sharp 
  Version 2 
 
 
Page 56 of 58  
 Group  3.15 2.67 .240 
 1.37 2.33 .557 
Time  0.14 0.79 .863 
 -8.61 0.67 <.001  
Group x time  -1.53 1.58 .327 
 -0.40 1.340  .765 
Hearing  0.07 0.57 .194 
 -0.02 0.05 .603 
Visual acuity  12.75  4.770  .008 
 0.24 4.470  .957 
Expectation s 1.02 0.59 .089 
 -0.79 0.56 .157 
Note .  ATTR=Adaptive Tests of Temporal Resolution, IADL= instrumental activities of daily 
living.  MCI=mild cognitive impairment. +For ATTR and Timed IADL lower scores reflect 
better performance.  
 
 [ADDRESS_286095] Size  
  
Overall  
(n=198)   
Adherent  
(n=189)  Non-
MCI  
(n=146)   
MCI  
(n=52 ) 
Central auditory processing composite  -0.[ADDRESS_286096] of Everyday Attention composite  0.04 0.08 -0.30 -0.02 
    Visual Elevator accuracy  0.01 0.03 -0.12 -0.19 
    Dual task decrement  0.10 0.13 -0.18 0.22 
Timed Instrumen tal Activities of Daily Living 
composite  -0.15 -0.21 0.09 -0.13 
Note .  MCI=mild cognitive impairment.  d effect sizes were calculated as pre-  to post - change in the pi[INVESTIGATOR_236275]-
ing condition relative to the music listening condition divided by [CONTACT_236342]-
tive values would indicate improvement.  Adherent analyses include thos e who completed 15 or more sessions 
of the assigned condition.  
 